,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,248,1,1,,72493,7858,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
1,328,1,1,,72493,7858,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  P388 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
2,421,1,3,,17390057,7858,Inactive,,,,,Cell Viability - BJ,Confirmatory,,
3,426,1,2,,17390057,7858,Inactive,,,,,Cell Viability - Jurkat,Confirmatory,,
4,427,1,1,,17390057,7858,Inactive,,,,,Cell Viability - Hek293,Confirmatory,,
5,433,1,1,,17390057,7858,Inactive,,,,,Cell Viability - HepG2,Confirmatory,,
6,434,1,2,,17390057,7858,Inactive,,,,,Cell Viability - MRC5,Confirmatory,,
7,435,1,2,,17390057,7858,Inactive,,,,,Cell Viability - SK-N-SH,Confirmatory,,
8,445,3,1,,17390057,7858,Inactive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
9,530,1,1,,17390057,7858,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
10,540,1,1,,17390057,7858,Inactive,,,,,Cell Viability - N2a,Confirmatory,,
11,541,1,1,,17390057,7858,Inactive,,,,,Cell Viability - NIH 3T3,Confirmatory,,
12,542,1,1,,17390057,7858,Inactive,,,,,Cell Viability - HUV-EC-C,Confirmatory,,
13,543,1,1,,17390057,7858,Inactive,,,,,Cell Viability - H-4-II-E,Confirmatory,,
14,544,2,1,,17390057,7858,Inactive,,,,,Cell Viability - SH-SY5Y,Confirmatory,,
15,545,1,1,,17390057,7858,Inactive,,,,,Cell Viability - Renal Proximal Tubule,Confirmatory,,
16,546,1,1,,17390057,7858,Inactive,,,,,Cell Viability - Mesenchymal,Confirmatory,,
17,584,1,3,,17390057,7858,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
18,585,1,4,,17390057,7858,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
19,595,1,3,,17390057,7858,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
20,596,1,2,,17390057,7858,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
21,603,1,2,,17390057,7858,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
22,605,1,2,,17390057,7858,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
23,654,1,1,,17390057,7858,Inactive,,,,,Cellular Toxicity (caspase-3) HepG2,Confirmatory,,
24,655,1,1,,17390057,7858,Inactive,,,,,Cellular Toxicity (caspase-3) Jurkat,Confirmatory,,
25,656,1,1,,17390057,7858,Inactive,,,,,Cellular Toxicity (caspase-3) HUV-EC-C,Confirmatory,,
26,657,1,1,,17390057,7858,Inactive,,,,,Cellular Toxicity (caspase-3) SHSY5Y,Confirmatory,,
27,658,1,1,,17390057,7858,Inactive,,,,,Cellular Toxicity (caspase-3) BJ,Confirmatory,,
28,659,1,1,,17390057,7858,Inactive,,,,,Cellular Toxicity (caspase-3) MRC-5,Confirmatory,,
29,660,1,1,,17390057,7858,Inactive,,,,,Cellular Toxicity (caspase-3) Mesangial,Confirmatory,,
30,661,1,1,,17390057,7858,Inactive,,,,,Cellular Toxicity (caspase-3) SK-N-SH,Confirmatory,,
31,662,1,1,,17390057,7858,Inactive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
32,663,1,1,,17390057,7858,Inactive,,,,,Cellular Toxicity (caspase-3) H-4-II-E,Confirmatory,,
33,664,1,1,,17390057,7858,Inactive,,,,,Cellular Toxicity (caspase-3) Hek293,Confirmatory,,
34,665,1,1,,17390057,7858,Inactive,,,,,Cellular Toxicity (caspase-3) N2a,Confirmatory,,
35,666,1,1,,17390057,7858,Inactive,,,,,Cellular Toxicity (caspase-3) NIH 3T3,Confirmatory,,
36,667,1,1,,17390057,7858,Inactive,,,,,Cellular Toxicity (caspase-3) Renal Proximal Tubule,Confirmatory,,
37,875,1,2,,17390057,7858,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
38,880,2,1,,17390057,7858,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
39,880,2,1,,17390057,7858,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
40,881,2,2,,17390057,7858,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
41,884,1,2,,17390057,7858,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
42,885,1,2,,17390057,7858,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
43,886,1,2,,17390057,7858,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
44,886,1,2,,17390057,7858,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
45,887,1,2,,17390057,7858,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
46,889,1,3,,17390057,7858,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
47,892,1,2,,17390057,7858,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
48,893,1,2,,17390057,7858,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
49,893,1,2,,17390057,7858,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
50,894,2,1,,17390057,7858,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
51,900,1,3,,17390057,7858,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
52,902,1,2,,17390057,7858,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
53,912,1,2,,17390057,7858,Inactive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
54,921,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP2-001,Confirmatory,,
55,923,1,2,,17390057,7858,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
56,924,1,2,,17390057,7858,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
57,925,1,2,,17390057,7858,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
58,926,1,2,,17390057,7858,Inconclusive,38016895.0,7253.0,12.5893,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
59,938,1,2,,17390057,7858,Inactive,38016895.0,7253.0,12.5893,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
60,946,1,2,,17390057,7858,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Dead Cells,Confirmatory,,
61,947,1,2,,17390057,7858,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Live Cells,Confirmatory,,
62,948,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 16 hr,Confirmatory,,
63,955,1,2,,17390057,7858,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Live Cells,Confirmatory,,
64,960,1,2,,17390057,7858,Inconclusive,,,39.8107,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Dead Cells,Confirmatory,,
65,961,1,2,,17390057,7858,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells,Confirmatory,,
66,962,1,2,,17390057,7858,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Live Cells,Confirmatory,,
67,963,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP1-003 - Assay at 24 hr,Confirmatory,,
68,964,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP1-003 - Assay at 40 hr,Confirmatory,,
69,965,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP2-003,Confirmatory,,
70,966,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP2-004,Confirmatory,,
71,967,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP2-005,Confirmatory,,
72,968,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP2-009,Confirmatory,,
73,969,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP2-011,Confirmatory,,
74,970,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP2-013,Confirmatory,,
75,971,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP2-015,Confirmatory,,
76,972,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP2-017,Confirmatory,,
77,973,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP2-019,Confirmatory,,
78,974,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP2-021,Confirmatory,,
79,975,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP2-023,Confirmatory,,
80,976,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP2-025,Confirmatory,,
81,977,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP2-002,Confirmatory,,
82,978,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP2-006,Confirmatory,,
83,979,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP2-007,Confirmatory,,
84,980,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP2-008,Confirmatory,,
85,981,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP2-010,Confirmatory,,
86,982,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP2-012,Confirmatory,,
87,983,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP2-014,Confirmatory,,
88,984,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP2-016,Confirmatory,,
89,985,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP2-018,Confirmatory,,
90,986,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP2-020,Confirmatory,,
91,987,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP2-022,Confirmatory,,
92,988,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP2-024,Confirmatory,,
93,989,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP2-026,Confirmatory,,
94,993,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 24 hr,Confirmatory,,
95,994,1,2,,17390057,7858,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 40 hr,Confirmatory,,
96,995,1,2,,17390057,7858,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
97,1030,2,1,,17390057,7858,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
98,1188,1,2,,48415074,7858,Active,,,,,DSSTox (EPAFHM) EPA Fathead Minnow Acute Toxicity,Other,,
99,1189,1,5,,48413171,7858,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results,Other,,
100,1194,1,3,,48413171,7858,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Salmonella Mutagenicity,Other,,
101,1205,1,4,,48413171,7858,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary MultiCellCall Results,Other,,
102,1208,1,3,,48413171,7858,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Rat Bioassay Results,Other,,
103,1452,1,1,,17390057,7858,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
104,1457,1,1,,17390057,7858,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
105,1458,1,1,,17390057,7858,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
106,1469,1,1,,17390057,7858,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
107,1471,2,1,,17390057,7858,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
108,1476,2,1,,17390057,7858,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
109,1477,1,1,,17390057,7858,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
110,1478,2,1,,17390057,7858,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
111,1479,1,2,,17390057,7858,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
112,1948,1,1,,17390057,7858,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
113,2101,1,1,,17390057,7858,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
114,2107,1,1,,17390057,7858,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
115,2112,1,1,,17390057,7858,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
116,2120,1,1,,17390057,7858,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Inducers of Hypoxia Response,Confirmatory,,
117,2517,2,1,,17390057,7858,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
118,2546,1,1,,17390057,7858,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
119,2549,1,1,,17390057,7858,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
120,2551,1,1,,17390057,7858,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
121,294759,6,2,,103532939,7858,Unspecified,,,,,Antibacterial activity against Mycobacterium tuberculosis H37Rv after 2 weeks by broth dilution method,Other,17331717.0,
122,294760,7,2,,103532939,7858,Inconclusive,,,,,Antibacterial activity against Mycobacterium avium 724S after 2 weeks by broth dilution method,Other,17331717.0,
123,294761,6,2,,103532939,7858,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus after 2 weeks by broth dilution method,Other,17331717.0,
124,294762,7,2,,103532939,7858,Inconclusive,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus 873 after 2 weeks by broth dilution method,Other,17331717.0,
125,294763,10,1,,103532939,7858,Inconclusive,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus 906 after 2 weeks by broth dilution method,Other,17331717.0,
126,294764,10,1,,103532939,7858,Inconclusive,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus 908 after 2 weeks by broth dilution method,Other,17331717.0,
127,294765,7,2,,103532939,7858,Inconclusive,,,,,Antibacterial activity against methicillin-resistant Staphylococcus aureus 910 after 2 weeks by broth dilution method,Other,17331717.0,
128,485290,1,1,,17390057,7858,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
129,588209,2,3,,103532939,7858,Unspecified,,,,,Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset,Other,20553011.0,
130,588210,2,4,,103532939,7858,Unspecified,,,,,Human drug-induced liver injury (DILI) modelling dataset from Ekins et al,Other,20843939.0,
131,588513,1,1,,17390057,7858,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
132,588514,1,1,,17390057,7858,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
133,588515,1,1,,17390057,7858,Inactive,124375976.0,367.0,,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
134,588516,1,1,,17390057,7858,Inactive,124375976.0,367.0,,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
135,588526,1,1,,17390057,7858,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
136,588527,1,1,,17390057,7858,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
137,588532,1,1,,17390057,7858,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
138,588533,1,1,,17390057,7858,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
139,588534,1,1,,17390057,7858,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
140,588535,1,1,,17390057,7858,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
141,588536,1,1,,17390057,7858,Inactive,216409692.0,5468.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
142,588537,1,1,,17390057,7858,Inactive,216409692.0,5468.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
143,588541,1,1,,17390057,7858,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
144,588543,1,1,,17390057,7858,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
145,588544,1,1,,17390057,7858,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
146,588545,1,1,,17390057,7858,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
147,588546,1,1,,17390057,7858,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
148,588547,1,1,,17390057,7858,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
149,588834,2,1,,17390057,7858,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
150,625144,5,5,,103532939,7858,Unspecified,239977155.0,,,IC50,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),Confirmatory,,
151,625145,4,7,,103532939,7858,Unspecified,20138087.0,10800.0,,IC50,DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4),Confirmatory,,
152,625146,5,5,,103532939,7858,Unspecified,126397.0,100009114.0,,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),Confirmatory,,
153,625147,4,7,,103532939,7858,Unspecified,395398606.0,4159.0,,IC50,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),Confirmatory,,
154,625148,4,7,,103532939,7858,Unspecified,60392672.0,4160.0,,IC50,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),Confirmatory,,
155,625149,4,7,,103532939,7858,Unspecified,729996.0,4161.0,,IC50,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),Confirmatory,,
156,625150,5,5,,103532939,7858,Unspecified,113978.0,4128.0,,IC50,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),Confirmatory,,
157,625151,4,7,,103532939,7858,Unspecified,113118.0,1128.0,,IC50,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
158,625152,4,7,,103532939,7858,Unspecified,113122.0,1129.0,,IC50,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
159,625153,4,7,,103532939,7858,Unspecified,113125.0,1131.0,,IC50,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
160,625154,4,7,,103532939,7858,Unspecified,23503039.0,1132.0,,IC50,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
161,625155,4,7,,103532939,7858,Unspecified,543761.0,1133.0,,IC50,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),Confirmatory,,
162,625156,1,9,,103532939,7858,Unspecified,128997.0,4886.0,,,DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY),Other,,
163,625157,6,2,,103532939,7858,Unspecified,1352610.0,4887.0,,IC50,DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY),Confirmatory,,
164,625158,3,4,,103532939,7858,Unspecified,,,,IC50,DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine),Confirmatory,,
165,625159,5,5,,103532939,7858,Unspecified,266646.0,24598.0,,IC50,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",Confirmatory,,
166,625160,1,9,,103532939,7858,Unspecified,266649.0,18126.0,,,"DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)",Other,,
167,625161,4,7,,103532939,7858,Unspecified,311033488.0,4985.0,,IC50,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",Confirmatory,,
168,625162,4,7,,103532939,7858,Unspecified,116242691.0,4986.0,,IC50,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",Confirmatory,,
169,625163,4,7,,103532939,7858,Unspecified,2851402.0,4988.0,,IC50,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",Confirmatory,,
170,625164,1,6,,103532939,7858,Unspecified,,,,,DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu),Other,,
171,625165,3,4,,103532939,7858,Unspecified,,,,IC50,DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP),Confirmatory,,
172,625166,3,4,,103532939,7858,Unspecified,,,,IC50,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),Confirmatory,,
173,625167,5,5,,103532939,7858,Unspecified,317373261.0,8654.0,,IC50,DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP),Confirmatory,,
174,625168,4,7,,103532939,7858,Unspecified,129557.0,5724.0,,IC50,DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF),Confirmatory,,
175,625169,1,6,,103532939,7858,Unspecified,,,,,DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF),Other,,
176,625170,3,4,,103532939,7858,Unspecified,,,,IC50,DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide),Confirmatory,,
177,625171,4,7,,103532939,7858,Unspecified,7531135.0,3757.0,,IC50,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),Confirmatory,,
178,625172,4,7,,103532939,7858,Unspecified,75071465.0,,,IC50,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),Confirmatory,,
179,625173,5,5,,103532939,7858,Unspecified,2822103.0,100009274.0,,IC50,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",Confirmatory,,
180,625174,5,5,,103532939,7858,Unspecified,266321.0,834.0,,IC50,"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)",Confirmatory,,
181,625175,5,5,,103532939,7858,Unspecified,115725.0,1511.0,,IC50,"DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC)",Confirmatory,,
182,625176,1,9,,103532939,7858,Unspecified,119292.0,1991.0,,,"DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA)",Other,,
183,625177,5,5,,103532939,7858,Unspecified,116852.0,4312.0,,IC50,"DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",Confirmatory,,
184,625178,5,5,,103532939,7858,Unspecified,269849668.0,4318.0,,IC50,"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",Confirmatory,,
185,625179,1,9,,103532939,7858,Unspecified,317373571.0,5578.0,,,DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone),Other,,
186,625180,5,5,,103532939,7858,Unspecified,232066.0,5595.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",Confirmatory,,
187,625181,5,5,,103532939,7858,Unspecified,119554.0,5594.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",Confirmatory,,
188,625182,5,5,,103532939,7858,Unspecified,2499600.0,1432.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",Confirmatory,,
189,625183,5,5,,103532939,7858,Unspecified,1352673.0,5530.0,,IC50,"DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP)",Confirmatory,,
190,625184,5,5,,103532939,7858,Unspecified,2811086.0,1956.0,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
191,625185,5,5,,103532939,7858,Unspecified,125370.0,2534.0,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
192,625186,5,5,,103532939,7858,Unspecified,119533.0,2064.0,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
193,625187,5,5,,103532939,7858,Unspecified,125474.0,3932.0,,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",Confirmatory,,
194,625188,1,9,,103532939,7858,Unspecified,33112650.0,5788.0,,,"DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)",Other,,
195,625189,1,7,,103532939,7858,Unspecified,,,,,"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)",Other,,
196,625190,4,5,,103532939,7858,Unspecified,,,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),Confirmatory,,
197,625191,4,7,,103532939,7858,Unspecified,112815.0,25075.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),Confirmatory,,
198,625192,4,7,,103532939,7858,Unspecified,543727.0,3356.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),Confirmatory,,
199,625193,5,5,,103532939,7858,Unspecified,113037.0,43.0,,IC50,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),Confirmatory,,
200,625194,4,7,,103532939,7858,Unspecified,231473.0,134.0,,IC50,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),Confirmatory,,
201,625195,4,7,,103532939,7858,Unspecified,543740.0,135.0,,IC50,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),Confirmatory,,
202,625196,5,6,,103532939,7858,Unspecified,803374855.0,140.0,,IC50,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),Confirmatory,,
203,625197,3,4,,103532939,7858,Unspecified,,,,IC50,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),Confirmatory,,
204,625198,4,7,,103532939,7858,Unspecified,1168247.0,29412.0,,IC50,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),Confirmatory,,
205,625199,4,7,,103532939,7858,Unspecified,543734.0,24173.0,,IC50,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),Confirmatory,,
206,625200,4,7,,103532939,7858,Unspecified,1168243.0,146.0,,IC50,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),Confirmatory,,
207,625201,4,7,,103532939,7858,Unspecified,1351829.0,150.0,,IC50,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),Confirmatory,,
208,625202,4,7,,103532939,7858,Unspecified,613504690.0,151.0,,IC50,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),Confirmatory,,
209,625203,4,7,,103532939,7858,Unspecified,20141211.0,152.0,,IC50,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),Confirmatory,,
210,625204,4,7,,103532939,7858,Unspecified,48429211.0,153.0,,IC50,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),Confirmatory,,
211,625205,4,7,,103532939,7858,Unspecified,296439450.0,154.0,,IC50,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),Confirmatory,,
212,625206,4,7,,103532939,7858,Unspecified,461604.0,155.0,,IC50,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),Confirmatory,,
213,625207,4,7,,103532939,7858,Unspecified,128616.0,6530.0,,IC50,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Confirmatory,,
214,625208,5,5,,103532939,7858,Unspecified,1168407.0,24192.0,,IC50,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),Confirmatory,,
215,625209,4,7,,103532939,7858,Unspecified,1703214.0,186.0,,IC50,DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A),Confirmatory,,
216,625210,3,4,,103532939,7858,Unspecified,,,,IC50,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",Confirmatory,,
217,625211,1,6,,103532939,7858,Unspecified,,,,,DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat)),Other,,
218,625212,3,4,,103532939,7858,Unspecified,,,,IC50,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),Confirmatory,,
219,625213,4,7,,103532939,7858,Unspecified,2506481.0,624.0,,IC50,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),Confirmatory,,
220,625214,1,9,,103532939,7858,Unspecified,550544247.0,799.0,,,DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon)),Other,,
221,625215,3,4,,103532939,7858,Unspecified,,,,IC50,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",Confirmatory,,
222,625216,3,4,,103532939,7858,Unspecified,,,,IC50,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",Confirmatory,,
223,625217,4,7,,103532939,7858,Unspecified,1168220.0,3357.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),Confirmatory,,
224,625218,4,7,,103532939,7858,Unspecified,112816.0,3358.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),Confirmatory,,
225,625219,3,4,,103532939,7858,Unspecified,,,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630),Confirmatory,,
226,625220,4,7,,103532939,7858,Unspecified,6224984.0,100135548.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),Confirmatory,,
227,625221,4,7,,103532939,7858,Unspecified,1703010.0,3362.0,,IC50,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),Confirmatory,,
228,625222,4,7,,103532939,7858,Unspecified,400630.0,6532.0,,IC50,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",Confirmatory,,
229,625223,4,7,,103532939,7858,Unspecified,74752153.0,10280.0,,IC50,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),Confirmatory,,
230,625224,3,4,,103532939,7858,Unspecified,,,,IC50,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),Confirmatory,,
231,625225,3,4,,103532939,7858,Unspecified,,,,IC50,"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)",Confirmatory,,
232,625226,4,7,,103532939,7858,Unspecified,128359.0,6869.0,,IC50,DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P),Confirmatory,,
233,625227,4,7,,103532939,7858,Unspecified,229462950.0,6865.0,,IC50,DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968),Confirmatory,,
234,625228,4,7,,103532939,7858,Unspecified,113832.0,24208.0,,IC50,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),Confirmatory,,
235,625229,5,5,,103532939,7858,Unspecified,254763392.0,6916.0,,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),Confirmatory,,
236,625230,1,6,,103532939,7858,Unspecified,,,,,"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)",Other,,
237,625231,4,7,,103532939,7858,Unspecified,143811474.0,2321.0,,IC50,DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF),Confirmatory,,
238,625232,1,9,,103532939,7858,Unspecified,418253.0,7433.0,,,DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP),Other,,
239,625233,4,7,,103532939,7858,Unspecified,586197.0,552.0,,IC50,DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr),Confirmatory,,
240,625234,3,4,,103532939,7858,Unspecified,,,,IC50,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",Confirmatory,,
241,625235,4,7,,103532939,7858,Unspecified,115562.0,1268.0,,IC50,DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A),Confirmatory,,
242,625236,5,5,,103532939,7858,Unspecified,115456.0,760.0,,IC50,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),Confirmatory,,
243,625237,4,7,,103532939,7858,Unspecified,1168965.0,729230.0,,IC50,DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1),Confirmatory,,
244,625238,4,7,,103532939,7858,Unspecified,1705894.0,1233.0,,IC50,DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC),Confirmatory,,
245,625239,4,7,,103532939,7858,Unspecified,1705896.0,1234.0,,IC50,DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha),Confirmatory,,
246,625240,1,9,,103532939,7858,Unspecified,108936015.0,3577.0,,,DRUGMATRIX: Chemokine CXCR1 (IL-8A),Other,,
247,625241,4,7,,103532939,7858,Unspecified,1352454.0,3579.0,,IC50,DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8),Confirmatory,,
248,625242,4,7,,103532939,7858,Unspecified,416772.0,886.0,,IC50,"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)",Confirmatory,,
249,625243,5,5,,103532939,7858,Unspecified,317373262.0,5742.0,,IC50,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),Confirmatory,,
250,625244,5,5,,103532939,7858,Unspecified,3915797.0,5743.0,,IC50,DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid),Confirmatory,,
251,625245,5,5,,103532939,7858,Unspecified,117144.0,1544.0,,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
252,625246,1,9,,103532939,7858,Unspecified,308153612.0,1548.0,,,"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Other,,
253,625247,5,5,,103532939,7858,Unspecified,60416369.0,1557.0,,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
254,625248,5,5,,103532939,7858,Unspecified,6686268.0,1559.0,,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
255,625249,5,5,,103532939,7858,Unspecified,84028191.0,1565.0,,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
256,625250,5,5,,103532939,7858,Unspecified,117250.0,1571.0,,IC50,"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",Confirmatory,,
257,625251,5,5,,103532939,7858,Unspecified,116241312.0,1576.0,,IC50,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",Confirmatory,,
258,625252,4,7,,103532939,7858,Unspecified,118228.0,1812.0,,IC50,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),Confirmatory,,
259,625253,4,7,,103532939,7858,Unspecified,118206.0,1813.0,,IC50,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),Confirmatory,,
260,625254,4,7,,103532939,7858,Unspecified,1169206.0,1814.0,,IC50,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),Confirmatory,,
261,625255,4,7,,103532939,7858,Unspecified,1345939.0,1815.0,,IC50,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),Confirmatory,,
262,625256,4,7,,103532939,7858,Unspecified,266667.0,6531.0,,IC50,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),Confirmatory,,
263,625257,4,7,,103532939,7858,Unspecified,119606.0,1909.0,,IC50,DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1),Confirmatory,,
264,625258,4,7,,103532939,7858,Unspecified,544257.0,2099.0,,IC50,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),Confirmatory,,
265,625259,4,7,,103532939,7858,Unspecified,6166154.0,2100.0,,IC50,DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol),Confirmatory,,
266,625260,3,4,,103532939,7858,Unspecified,,,,IC50,"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)",Confirmatory,,
267,625261,3,4,,103532939,7858,Unspecified,,,,IC50,"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)",Confirmatory,,
268,625262,3,4,,103532939,7858,Unspecified,,,,IC50,"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)",Confirmatory,,
269,625263,4,7,,103532939,7858,Unspecified,121069.0,2908.0,,IC50,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),Confirmatory,,
270,625264,3,4,,103532939,7858,Unspecified,,,,IC50,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",Confirmatory,,
271,625265,1,6,,103532939,7858,Unspecified,,,,,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",Other,,
272,625266,3,4,,103532939,7858,Unspecified,,,,IC50,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",Confirmatory,,
273,625267,3,4,,103532939,7858,Unspecified,,,,IC50,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",Confirmatory,,
274,625268,4,2,,103532939,7858,Unspecified,121579.0,24397.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
275,625268,4,2,,103532939,7858,Unspecified,121580.0,114516.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
276,625268,4,2,,103532939,7858,Unspecified,121604.0,25456.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
277,625268,4,2,,103532939,7858,Unspecified,12230887.0,25674.0,,IC50,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",Confirmatory,,
278,625269,4,7,,103532939,7858,Unspecified,547645.0,3269.0,,IC50,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",Confirmatory,,
279,625270,4,7,,103532939,7858,Unspecified,123120.0,3274.0,,IC50,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),Confirmatory,,
280,625271,5,5,,103532939,7858,Unspecified,123343.0,3156.0,,IC50,DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA),Confirmatory,,
281,625272,3,4,,103532939,7858,Unspecified,,,,IC50,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",Confirmatory,,
282,625273,4,6,,103532939,7858,Unspecified,124531.0,24954.0,,IC50,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),Confirmatory,,
283,625274,1,6,,103532939,7858,Unspecified,,,,,DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta),Other,,
284,625275,3,4,,103532939,7858,Unspecified,,,,IC50,"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)",Confirmatory,,
285,625295,1,3,,103532939,7858,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) validation dataset; compound DILI positive/negative as observed in Pfizer data,Other,22194678.0,
286,651631,4,1,,144207398,7858,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
287,651631,4,1,,144213815,7858,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
288,651632,4,1,,144207398,7858,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
289,651632,4,1,,144213815,7858,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
290,651633,4,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
291,651633,4,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
292,651634,4,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
293,651634,4,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
294,651741,1,1,,17390057,7858,Inactive,20149576.0,4780.0,,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
295,651743,1,1,,17390057,7858,Inactive,269849759.0,7157.0,,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
296,651749,1,1,,17390057,7858,Inactive,34577122.0,4790.0,,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
297,651751,1,1,,17390057,7858,Inactive,5702233.0,84385.0,,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
298,651754,1,1,,17390057,7858,Inactive,,,,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay,Confirmatory,,
299,651755,1,1,,17390057,7858,Inactive,,,,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay,Confirmatory,,
300,651757,1,1,,17390057,7858,Inactive,25952111.0,7124.0,,Potency,qHTS assay to identify small molecules that stimulate Tumor Necrosis Factor-alpha (TNF-alpha) secretion,Confirmatory,,
301,651758,1,1,,17390057,7858,Inconclusive,186368.0,3576.0,,Potency,qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion,Confirmatory,,
302,651777,1,1,,17390057,7858,Inactive,51095037.0,196.0,,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
303,651778,1,1,,17390057,7858,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
304,651802,1,1,,17390057,7858,Inactive,49066040.0,6097.0,,Potency,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
305,651838,1,1,,17390057,7858,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
306,651838,1,1,1.0,17390057,7858,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
307,651838,1,1,2.0,17390057,7858,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
308,651838,1,1,3.0,17390057,7858,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
309,651838,1,1,4.0,17390057,7858,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
310,651838,1,1,5.0,17390057,7858,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
311,651838,1,1,6.0,17390057,7858,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
312,651838,1,1,7.0,17390057,7858,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
313,651838,1,1,8.0,17390057,7858,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
314,720516,2,1,,144207398,7858,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
315,720516,2,1,,144213815,7858,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
316,720552,2,1,,144207398,7858,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
317,720552,2,1,,144213815,7858,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
318,720634,2,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
319,720634,2,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
320,720635,2,1,,144207398,7858,Inconclusive,,,3.5885,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
321,720635,2,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
322,720636,1,1,,17390057,7858,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
323,720637,2,1,,144207398,7858,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
324,720637,2,1,,144213815,7858,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
325,720652,1,1,,17390057,7858,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
326,720653,1,1,,17390057,7858,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
327,720659,1,1,,17390057,7858,Inactive,325495557.0,8856.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
328,720674,2,2,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
329,720674,2,2,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
330,720675,2,2,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
331,720675,2,2,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
332,720678,2,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
333,720678,2,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
334,720679,2,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
335,720679,2,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
336,720680,2,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
337,720680,2,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
338,720681,2,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
339,720681,2,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
340,720682,2,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
341,720682,2,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
342,720683,2,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
343,720683,2,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
344,720684,2,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
345,720684,2,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
346,720685,2,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
347,720685,2,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
348,720686,2,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
349,720686,2,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
350,720687,2,2,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
351,720687,2,2,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
352,720691,4,1,,144207398,7858,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
353,720691,4,1,,144213815,7858,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
354,720692,3,1,,144207398,7858,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
355,720692,3,1,,144213815,7858,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
356,720693,3,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
357,720693,3,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
358,720719,2,1,,144207398,7858,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
359,720719,2,1,,144213815,7858,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
360,720725,2,1,,144207398,7858,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
361,720725,2,1,,144213815,7858,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
362,743012,3,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
363,743012,3,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
364,743014,3,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
365,743014,3,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
366,743015,3,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
367,743015,3,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
368,743033,3,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
369,743033,3,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
370,743035,2,1,,144207398,7858,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
371,743035,2,1,,144213815,7858,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
372,743036,2,1,,144207398,7858,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
373,743036,2,1,,144213815,7858,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
374,743040,3,1,,144207398,7858,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
375,743040,3,1,,144213815,7858,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
376,743041,3,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
377,743041,3,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
378,743042,3,1,,144207398,7858,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
379,743042,3,1,,144213815,7858,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
380,743053,2,1,,144207398,7858,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
381,743053,2,1,,144213815,7858,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
382,743054,2,1,,144207398,7858,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
383,743054,2,1,,144213815,7858,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
384,743063,2,1,,144207398,7858,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
385,743063,2,1,,144213815,7858,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
386,743064,3,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
387,743064,3,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
388,743065,3,1,,144207398,7858,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
389,743065,3,1,,144213815,7858,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
390,743066,3,1,,144207398,7858,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
391,743066,3,1,,144213815,7858,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
392,743067,2,1,,144207398,7858,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
393,743067,2,1,,144213815,7858,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
394,743069,2,1,,144207398,7858,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
395,743069,2,1,,144213815,7858,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
396,743074,2,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
397,743074,2,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
398,743075,2,1,,144207398,7858,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
399,743075,2,1,,144213815,7858,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
400,743077,2,1,,144207398,7858,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
401,743077,2,1,,144213815,7858,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
402,743078,2,1,,144207398,7858,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
403,743078,2,1,,144213815,7858,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
404,743079,3,1,,144207398,7858,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
405,743079,3,1,,144213815,7858,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
406,743080,3,1,,144207398,7858,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
407,743080,3,1,,144213815,7858,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
408,743081,3,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
409,743081,3,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
410,743083,3,1,,144207398,7858,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
411,743083,3,1,,144213815,7858,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
412,743084,3,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
413,743084,3,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
414,743085,3,1,,144207398,7858,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
415,743085,3,1,,144213815,7858,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
416,743086,3,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
417,743086,3,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
418,743091,2,1,,144207398,7858,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
419,743091,2,1,,144213815,7858,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
420,743094,3,1,,144207398,7858,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
421,743094,3,1,,144213815,7858,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
422,743122,2,1,,144207398,7858,Inconclusive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
423,743122,2,1,,144213815,7858,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
424,743139,2,1,,144207398,7858,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
425,743139,2,1,,144213815,7858,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
426,743140,2,1,,144207398,7858,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
427,743140,2,1,,144213815,7858,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
428,743191,3,1,,144207398,7858,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
429,743191,3,1,,144213815,7858,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
430,743194,3,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
431,743194,3,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
432,743199,2,1,,144207398,7858,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
433,743199,2,1,,144213815,7858,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
434,743202,4,1,,144207398,7858,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
435,743202,4,1,,144213815,7858,Inconclusive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
436,743203,3,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
437,743203,3,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
438,743209,3,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
439,743209,3,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
440,743210,4,1,,144207398,7858,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
441,743210,4,1,,144213815,7858,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
442,743211,3,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
443,743211,3,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
444,743212,3,1,,144207398,7858,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
445,743212,3,1,,144213815,7858,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
446,743213,3,1,,144207398,7858,Inconclusive,,,0.1812,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
447,743213,3,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
448,743215,3,1,,144207398,7858,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
449,743215,3,1,,144213815,7858,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
450,743217,3,1,,144207398,7858,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
451,743217,3,1,,144213815,7858,Inconclusive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
452,743218,3,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
453,743218,3,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
454,743219,3,1,,144207398,7858,Inactive,20149576.0,4780.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
455,743219,3,1,,144213815,7858,Inconclusive,20149576.0,4780.0,51.435,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
456,743220,3,1,,144207398,7858,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
457,743220,3,1,,144213815,7858,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
458,743221,3,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
459,743221,3,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
460,743222,3,1,,144207398,7858,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
461,743222,3,1,,144213815,7858,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
462,743223,3,1,,144207398,7858,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
463,743223,3,1,,144213815,7858,Inconclusive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
464,743224,3,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
465,743224,3,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
466,743225,3,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
467,743225,3,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
468,743226,2,1,,144207398,7858,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
469,743226,2,1,,144213815,7858,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
470,743227,2,1,,144207398,7858,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
471,743227,2,1,,144213815,7858,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
472,743228,3,1,,144207398,7858,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
473,743228,3,1,,144213815,7858,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
474,743239,2,1,,144207398,7858,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
475,743239,2,1,,144213815,7858,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
476,743240,2,1,,144207398,7858,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
477,743240,2,1,,144213815,7858,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
478,743241,2,1,,144207398,7858,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
479,743241,2,1,,144213815,7858,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
480,743242,2,1,,144207398,7858,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
481,743242,2,1,,144213815,7858,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
482,743288,1,1,,17390057,7858,Inactive,,,,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
483,743292,1,1,,17390057,7858,Inactive,,,,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
484,809891,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 102/14,Other,,
485,810250,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 102/14,Other,,
486,810251,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 102/14,Other,,
487,810252,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 102/14,Other,,
488,810253,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 102/14,Other,,
489,810254,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 102/14,Other,,
490,810255,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 102/14,Other,,
491,810256,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 102/14,Other,,
492,810257,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 102/14,Other,,
493,810258,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 102/14,Other,,
494,810259,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 102/14,Other,,
495,810260,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 102/14,Other,,
496,810261,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 102/15,Other,,
497,810262,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 102/15,Other,,
498,810263,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 102/15,Other,,
499,810264,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 102/15,Other,,
500,810265,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 102/15,Other,,
501,810266,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 102/15,Other,,
502,810267,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 102/15,Other,,
503,810268,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 102/15,Other,,
504,810269,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 102/15,Other,,
505,810270,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 102/15,Other,,
506,810271,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 102/15,Other,,
507,810272,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 102/15,Other,,
508,810273,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 102/15,Other,,
509,810274,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 102/15,Other,,
510,810275,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 102/15,Other,,
511,810276,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 102/15,Other,,
512,810277,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 102/15,Other,,
513,810278,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 102/16,Other,,
514,810279,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 102/16,Other,,
515,810280,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 102/16,Other,,
516,810281,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 102/16,Other,,
517,810282,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 102/16,Other,,
518,810283,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 102/16,Other,,
519,810284,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 102/16,Other,,
520,810285,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 102/16,Other,,
521,810286,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 102/16,Other,,
522,810287,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 102/16,Other,,
523,810288,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 102/16,Other,,
524,810289,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 102/16,Other,,
525,810290,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 102/16,Other,,
526,810291,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 102/16,Other,,
527,810292,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 102/16,Other,,
528,810293,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 102/16,Other,,
529,810294,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 102/16,Other,,
530,810331,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 103/13,Other,,
531,810332,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 103/13,Other,,
532,810333,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 103/13,Other,,
533,810334,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 103/13,Other,,
534,810335,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 103/13,Other,,
535,810336,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 103/13,Other,,
536,810337,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 103/13,Other,,
537,810338,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 103/13,Other,,
538,810339,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 103/13,Other,,
539,810655,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 103/5,Other,,
540,810656,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 103/5,Other,,
541,810700,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 103/13,Other,,
542,810701,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 103/13,Other,,
543,810702,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 103/14,Other,,
544,810703,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 103/14,Other,,
545,810704,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 103/14,Other,,
546,810705,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 103/14,Other,,
547,810706,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 103/14,Other,,
548,810707,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 103/14,Other,,
549,810708,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 103/14,Other,,
550,810709,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 103/14,Other,,
551,810710,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 103/14,Other,,
552,810711,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 103/14,Other,,
553,810712,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 103/14,Other,,
554,810713,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 103/14,Other,,
555,810714,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 103/14,Other,,
556,810715,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 103/14,Other,,
557,810716,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 103/14,Other,,
558,810717,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 103/14,Other,,
559,810718,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 103/14,Other,,
560,810719,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 103/15,Other,,
561,810720,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 103/15,Other,,
562,810721,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 103/15,Other,,
563,810722,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 103/15,Other,,
564,810723,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 103/15,Other,,
565,810724,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 103/15,Other,,
566,810725,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 103/15,Other,,
567,810726,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 103/15,Other,,
568,810727,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 103/15,Other,,
569,810728,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 103/15,Other,,
570,810729,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 103/15,Other,,
571,810730,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 103/15,Other,,
572,810731,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 103/15,Other,,
573,810732,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 103/15,Other,,
574,810733,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 103/15,Other,,
575,810734,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 103/15,Other,,
576,810735,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 103/15,Other,,
577,810736,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 103/16,Other,,
578,810737,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 103/16,Other,,
579,811399,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 102/5,Other,,
580,811400,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 102/5,Other,,
581,811401,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 102/6,Other,,
582,811402,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 102/6,Other,,
583,811403,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 102/6,Other,,
584,811404,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 102/6,Other,,
585,811405,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 102/6,Other,,
586,811406,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 102/6,Other,,
587,811407,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 102/6,Other,,
588,811408,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 102/6,Other,,
589,811409,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 102/6,Other,,
590,811410,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 102/6,Other,,
591,811411,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 102/6,Other,,
592,811412,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 102/6,Other,,
593,811413,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 102/6,Other,,
594,811414,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 102/6,Other,,
595,811415,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 102/6,Other,,
596,811416,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 102/6,Other,,
597,811417,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 102/6,Other,,
598,811418,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 102/7,Other,,
599,811419,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 102/7,Other,,
600,811420,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 102/7,Other,,
601,811421,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 102/7,Other,,
602,811422,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 102/7,Other,,
603,811423,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 102/7,Other,,
604,811424,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 102/7,Other,,
605,811425,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 102/7,Other,,
606,811426,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 102/7,Other,,
607,811427,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 102/7,Other,,
608,811770,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 102/7,Other,,
609,811771,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 102/7,Other,,
610,811772,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 102/7,Other,,
611,811773,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 102/7,Other,,
612,811774,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 102/7,Other,,
613,811775,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 102/7,Other,,
614,811776,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 102/7,Other,,
615,811777,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 102/8,Other,,
616,811778,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 102/8,Other,,
617,811779,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 102/8,Other,,
618,811780,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 102/8,Other,,
619,811781,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 102/8,Other,,
620,811782,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 102/8,Other,,
621,811783,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 102/8,Other,,
622,811784,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 102/8,Other,,
623,811785,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 102/8,Other,,
624,811786,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 102/8,Other,,
625,811787,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 102/8,Other,,
626,811788,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 102/8,Other,,
627,811823,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 103/5,Other,,
628,811824,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 103/5,Other,,
629,811825,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 103/5,Other,,
630,811826,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 103/5,Other,,
631,811827,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 103/5,Other,,
632,811828,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 103/5,Other,,
633,811829,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 103/5,Other,,
634,811830,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 103/5,Other,,
635,811831,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 103/5,Other,,
636,811832,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 103/5,Other,,
637,811833,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 103/5,Other,,
638,811834,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 103/5,Other,,
639,811835,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 103/5,Other,,
640,811836,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 103/5,Other,,
641,811837,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 103/5,Other,,
642,811838,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 103/6,Other,,
643,811839,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 103/6,Other,,
644,811840,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 103/6,Other,,
645,811841,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 103/6,Other,,
646,811842,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 103/6,Other,,
647,811843,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 103/6,Other,,
648,811844,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 103/6,Other,,
649,811845,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 103/6,Other,,
650,811846,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 103/6,Other,,
651,811847,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 103/6,Other,,
652,811848,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 103/6,Other,,
653,811849,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 103/6,Other,,
654,811850,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 103/6,Other,,
655,811851,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 103/6,Other,,
656,811852,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 103/6,Other,,
657,811853,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 103/6,Other,,
658,811854,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 103/6,Other,,
659,811855,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 103/7,Other,,
660,811856,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 103/7,Other,,
661,811857,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 103/7,Other,,
662,811858,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 103/7,Other,,
663,811859,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 103/7,Other,,
664,812175,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 103/7,Other,,
665,812176,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 103/7,Other,,
666,812177,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 103/7,Other,,
667,812178,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 103/7,Other,,
668,812179,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 103/7,Other,,
669,812180,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 103/7,Other,,
670,812181,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 103/7,Other,,
671,812182,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 103/7,Other,,
672,812183,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 103/7,Other,,
673,812184,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 103/7,Other,,
674,812221,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 103/16,Other,,
675,812222,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 103/16,Other,,
676,812223,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 103/16,Other,,
677,812224,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 103/16,Other,,
678,812225,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 103/16,Other,,
679,812226,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 103/16,Other,,
680,812227,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 103/16,Other,,
681,812228,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 103/16,Other,,
682,812229,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 103/16,Other,,
683,812230,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 103/16,Other,,
684,812231,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 103/16,Other,,
685,812232,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 103/16,Other,,
686,812233,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 103/16,Other,,
687,812234,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 103/16,Other,,
688,812235,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 103/16,Other,,
689,812878,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 102/8,Other,,
690,812879,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 102/8,Other,,
691,812880,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 102/8,Other,,
692,812881,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 102/8,Other,,
693,812882,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 102/8,Other,,
694,812883,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 102/9,Other,,
695,812884,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 102/9,Other,,
696,812885,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 102/9,Other,,
697,812886,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 102/9,Other,,
698,812887,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 102/9,Other,,
699,812888,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 102/9,Other,,
700,812889,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 102/9,Other,,
701,812890,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 102/9,Other,,
702,812891,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 102/9,Other,,
703,812892,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 102/9,Other,,
704,812893,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 102/9,Other,,
705,812894,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 102/9,Other,,
706,812895,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 102/9,Other,,
707,812896,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 102/9,Other,,
708,812897,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 102/9,Other,,
709,813211,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 102/9,Other,,
710,813212,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 102/9,Other,,
711,813213,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 102/10,Other,,
712,813214,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 102/10,Other,,
713,813215,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 102/10,Other,,
714,813216,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 102/10,Other,,
715,813217,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 102/10,Other,,
716,813218,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 102/10,Other,,
717,813219,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 102/10,Other,,
718,813220,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 102/10,Other,,
719,813221,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 102/10,Other,,
720,813222,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 102/10,Other,,
721,813223,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 102/10,Other,,
722,813224,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 102/10,Other,,
723,813225,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 102/10,Other,,
724,813226,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 102/10,Other,,
725,813227,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 102/10,Other,,
726,813228,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 102/10,Other,,
727,813229,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 102/10,Other,,
728,813230,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 102/11,Other,,
729,813231,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 102/11,Other,,
730,813232,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 102/11,Other,,
731,813233,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 102/11,Other,,
732,813234,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 102/11,Other,,
733,813235,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 102/11,Other,,
734,813236,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 102/11,Other,,
735,813237,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 102/11,Other,,
736,813238,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 102/11,Other,,
737,813274,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 103/7,Other,,
738,813275,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 103/7,Other,,
739,813276,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 103/8,Other,,
740,813277,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 103/8,Other,,
741,813278,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 103/8,Other,,
742,813279,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 103/8,Other,,
743,813280,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 103/8,Other,,
744,813281,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 103/8,Other,,
745,813282,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 103/8,Other,,
746,813283,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 103/8,Other,,
747,813284,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 103/8,Other,,
748,813285,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 103/8,Other,,
749,813286,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 103/8,Other,,
750,813287,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 103/8,Other,,
751,813288,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 103/8,Other,,
752,813289,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 103/8,Other,,
753,813290,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 103/8,Other,,
754,813291,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 103/8,Other,,
755,813292,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 103/8,Other,,
756,813293,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 103/9,Other,,
757,813294,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 103/9,Other,,
758,813295,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 103/9,Other,,
759,813296,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 103/9,Other,,
760,813297,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 103/9,Other,,
761,813298,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 103/9,Other,,
762,813299,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 103/9,Other,,
763,813300,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 103/9,Other,,
764,813616,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 103/9,Other,,
765,813617,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 103/9,Other,,
766,813618,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 103/9,Other,,
767,813619,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 103/9,Other,,
768,813620,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 103/9,Other,,
769,813621,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 103/9,Other,,
770,813622,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 103/9,Other,,
771,813623,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 103/9,Other,,
772,813624,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 103/9,Other,,
773,813625,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 103/10,Other,,
774,813626,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 103/10,Other,,
775,813627,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 103/10,Other,,
776,813628,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 103/10,Other,,
777,813629,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 103/10,Other,,
778,813630,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 103/10,Other,,
779,813631,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 103/10,Other,,
780,813632,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 103/10,Other,,
781,813633,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 103/10,Other,,
782,813634,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 103/10,Other,,
783,813635,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 103/10,Other,,
784,814329,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 102/11,Other,,
785,814330,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 102/11,Other,,
786,814331,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 102/11,Other,,
787,814332,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 102/11,Other,,
788,814333,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 102/11,Other,,
789,814334,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 102/11,Other,,
790,814335,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 102/11,Other,,
791,814336,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 102/11,Other,,
792,814337,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 102/12,Other,,
793,814338,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 102/12,Other,,
794,814652,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 102/12,Other,,
795,814653,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 102/12,Other,,
796,814654,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 102/12,Other,,
797,814655,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 102/12,Other,,
798,814656,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 102/12,Other,,
799,814657,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 102/12,Other,,
800,814658,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 102/12,Other,,
801,814659,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 102/12,Other,,
802,814660,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 102/12,Other,,
803,814661,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 102/12,Other,,
804,814662,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 102/12,Other,,
805,814663,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 102/12,Other,,
806,814664,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 102/12,Other,,
807,814665,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 102/12,Other,,
808,814666,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 102/12,Other,,
809,814667,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 102/13,Other,,
810,814668,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 102/13,Other,,
811,814669,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 102/13,Other,,
812,814670,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 102/13,Other,,
813,814671,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 102/13,Other,,
814,814672,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 102/13,Other,,
815,814673,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 102/13,Other,,
816,814674,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 102/13,Other,,
817,814675,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 102/13,Other,,
818,814676,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 102/13,Other,,
819,814677,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 102/13,Other,,
820,814678,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 102/13,Other,,
821,814679,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 102/13,Other,,
822,814680,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 102/13,Other,,
823,814681,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 102/13,Other,,
824,814682,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 102/13,Other,,
825,814683,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 102/13,Other,,
826,814684,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 102/14,Other,,
827,814685,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 102/14,Other,,
828,814686,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 102/14,Other,,
829,814687,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 102/14,Other,,
830,814688,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 102/14,Other,,
831,814724,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 103/10,Other,,
832,814725,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 103/10,Other,,
833,814726,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 103/10,Other,,
834,814727,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 103/10,Other,,
835,814728,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 103/10,Other,,
836,814729,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 103/10,Other,,
837,814730,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 103/11,Other,,
838,814731,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 103/11,Other,,
839,814732,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 103/11,Other,,
840,814733,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 103/11,Other,,
841,814734,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 103/11,Other,,
842,814735,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 103/11,Other,,
843,814736,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 103/11,Other,,
844,814737,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 103/11,Other,,
845,814738,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 103/11,Other,,
846,814739,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 103/11,Other,,
847,814740,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 103/11,Other,,
848,814741,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 103/11,Other,,
849,815057,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 103/11,Other,,
850,815058,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 103/11,Other,,
851,815059,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 103/11,Other,,
852,815060,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 103/11,Other,,
853,815061,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 103/11,Other,,
854,815062,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 103/12,Other,,
855,815063,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 103/12,Other,,
856,815064,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 103/12,Other,,
857,815065,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 103/12,Other,,
858,815066,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 103/12,Other,,
859,815067,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 103/12,Other,,
860,815068,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 103/12,Other,,
861,815069,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 103/12,Other,,
862,815070,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 103/12,Other,,
863,815071,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 103/12,Other,,
864,815072,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 103/12,Other,,
865,815073,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 103/12,Other,,
866,815074,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 103/12,Other,,
867,815075,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 103/12,Other,,
868,815076,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 103/12,Other,,
869,815077,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: APTT (Activated Partial Thromboplastin Time); Study_ID: 103/12,Other,,
870,815078,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Hematology; Assay: FIBRINO (Fibrinogen); Study_ID: 103/12,Other,,
871,815079,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 103/13,Other,,
872,815080,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 103/13,Other,,
873,815081,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 103/13,Other,,
874,815082,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 103/13,Other,,
875,815083,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 103/13,Other,,
876,815084,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 103/13,Other,,
877,838870,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: 102/5,Other,,
878,838871,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: 102/5,Other,,
879,838872,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: 102/5,Other,,
880,838873,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: 102/5,Other,,
881,838874,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: 102/5,Other,,
882,838875,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: 102/5,Other,,
883,838876,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: RETIRBC (Reticulocytes/Erythrocytes); Study_ID: 102/5,Other,,
884,838877,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: 102/5,Other,,
885,838878,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: 102/5,Other,,
886,838879,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: 102/5,Other,,
887,838880,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: 102/5,Other,,
888,838881,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: 102/5,Other,,
889,838882,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: 102/5,Other,,
890,838883,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: 102/5,Other,,
891,838884,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Hematology; Assay: PT (Prothrombin Time); Study_ID: 102/5,Other,,
892,872163,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 102/5,Other,,
893,872164,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 102/5,Other,,
894,872165,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 102/5,Other,,
895,872166,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 102/5,Other,,
896,872167,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 102/5,Other,,
897,872168,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 102/5,Other,,
898,872169,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 102/5,Other,,
899,872170,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 102/5,Other,,
900,872171,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 102/5,Other,,
901,872172,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 102/5,Other,,
902,872281,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 103/9,Other,,
903,872282,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 103/9,Other,,
904,872283,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 103/9,Other,,
905,872284,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 103/9,Other,,
906,872285,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 103/9,Other,,
907,872286,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 103/9,Other,,
908,872287,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 103/9,Other,,
909,872288,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 103/9,Other,,
910,872289,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 103/9,Other,,
911,872290,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 103/9,Other,,
912,872291,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 103/9,Other,,
913,872292,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 103/9,Other,,
914,872293,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 103/9,Other,,
915,872975,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 103/10,Other,,
916,872976,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 103/10,Other,,
917,872977,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 103/10,Other,,
918,872978,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 103/10,Other,,
919,872979,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 103/10,Other,,
920,872980,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 103/10,Other,,
921,872981,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 103/10,Other,,
922,872982,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 103/10,Other,,
923,872983,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 103/10,Other,,
924,872984,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 103/10,Other,,
925,872985,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 103/10,Other,,
926,872986,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 103/10,Other,,
927,872987,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 103/10,Other,,
928,872988,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 103/10,Other,,
929,872989,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 103/10,Other,,
930,872990,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 103/10,Other,,
931,872991,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 103/10,Other,,
932,872992,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 103/10,Other,,
933,872993,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 103/10,Other,,
934,872994,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 103/10,Other,,
935,872995,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 103/10,Other,,
936,872996,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 103/11,Other,,
937,872997,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 103/11,Other,,
938,872998,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 103/11,Other,,
939,872999,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 103/11,Other,,
940,873000,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 103/11,Other,,
941,873001,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 103/11,Other,,
942,873002,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 103/11,Other,,
943,873003,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 103/11,Other,,
944,873004,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 103/11,Other,,
945,873005,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 103/11,Other,,
946,873006,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 103/11,Other,,
947,873007,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 103/11,Other,,
948,873008,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 103/11,Other,,
949,873154,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 102/12,Other,,
950,873155,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 102/12,Other,,
951,873156,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 102/12,Other,,
952,873841,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 102/12,Other,,
953,873842,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 102/12,Other,,
954,873843,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 102/12,Other,,
955,873844,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 102/12,Other,,
956,873845,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 102/12,Other,,
957,873846,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 102/12,Other,,
958,873847,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 102/12,Other,,
959,873848,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 102/12,Other,,
960,873849,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 102/12,Other,,
961,873850,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 102/12,Other,,
962,873851,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 102/12,Other,,
963,873852,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 102/13,Other,,
964,873853,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 102/13,Other,,
965,873854,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 102/13,Other,,
966,873855,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 102/13,Other,,
967,873856,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 102/13,Other,,
968,873857,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 102/13,Other,,
969,873858,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 102/13,Other,,
970,873859,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 102/13,Other,,
971,873860,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 102/13,Other,,
972,873861,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 102/13,Other,,
973,873862,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 102/13,Other,,
974,873863,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 102/13,Other,,
975,873864,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 102/13,Other,,
976,873865,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 102/13,Other,,
977,873866,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 102/13,Other,,
978,873867,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 102/13,Other,,
979,873868,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 102/13,Other,,
980,873869,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 102/13,Other,,
981,873870,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 102/13,Other,,
982,873871,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 102/13,Other,,
983,873872,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 102/13,Other,,
984,873873,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 102/14,Other,,
985,873874,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 102/14,Other,,
986,873875,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 102/14,Other,,
987,873876,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 102/14,Other,,
988,873877,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 102/14,Other,,
989,873878,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 102/14,Other,,
990,873879,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 102/14,Other,,
991,873880,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 102/14,Other,,
992,873881,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 102/14,Other,,
993,873882,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 102/14,Other,,
994,873883,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 102/14,Other,,
995,873884,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 102/14,Other,,
996,873885,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 102/14,Other,,
997,874363,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 102/5,Other,,
998,874364,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 102/5,Other,,
999,874365,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 102/5,Other,,
1000,874366,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 102/5,Other,,
1001,874367,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 102/5,Other,,
1002,874368,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 102/5,Other,,
1003,874369,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 102/5,Other,,
1004,874370,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 102/5,Other,,
1005,874371,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 102/5,Other,,
1006,874372,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 102/5,Other,,
1007,874373,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 102/5,Other,,
1008,874374,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 102/6,Other,,
1009,874375,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 102/6,Other,,
1010,874376,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 102/6,Other,,
1011,874377,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 102/6,Other,,
1012,874378,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 102/6,Other,,
1013,874379,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 102/6,Other,,
1014,874380,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 102/6,Other,,
1015,874381,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 102/6,Other,,
1016,874382,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 102/6,Other,,
1017,874383,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 102/6,Other,,
1018,874384,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 102/6,Other,,
1019,874385,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 102/6,Other,,
1020,874386,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 102/6,Other,,
1021,875067,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 102/6,Other,,
1022,875068,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 102/6,Other,,
1023,875069,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 102/6,Other,,
1024,875070,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 102/6,Other,,
1025,875071,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 102/6,Other,,
1026,875072,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 102/6,Other,,
1027,875073,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 102/6,Other,,
1028,875074,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 102/6,Other,,
1029,875075,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 102/7,Other,,
1030,875076,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 102/7,Other,,
1031,875077,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 102/7,Other,,
1032,875078,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 102/7,Other,,
1033,875079,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 102/7,Other,,
1034,875080,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 102/7,Other,,
1035,875081,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 102/7,Other,,
1036,875082,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 102/7,Other,,
1037,875083,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 102/7,Other,,
1038,875084,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 102/7,Other,,
1039,875085,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 102/7,Other,,
1040,875086,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 102/7,Other,,
1041,875087,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 102/7,Other,,
1042,875088,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 102/7,Other,,
1043,875089,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 102/7,Other,,
1044,875090,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 102/7,Other,,
1045,875199,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 103/11,Other,,
1046,875200,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 103/11,Other,,
1047,875201,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 103/11,Other,,
1048,875202,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 103/11,Other,,
1049,875203,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 103/11,Other,,
1050,875886,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 103/11,Other,,
1051,875887,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 103/11,Other,,
1052,875888,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 103/11,Other,,
1053,875889,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 103/12,Other,,
1054,875890,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 103/12,Other,,
1055,875891,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 103/12,Other,,
1056,875892,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 103/12,Other,,
1057,875893,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 103/12,Other,,
1058,875894,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 103/12,Other,,
1059,875895,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 103/12,Other,,
1060,875896,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 103/12,Other,,
1061,875897,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 103/12,Other,,
1062,875898,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 103/12,Other,,
1063,875899,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 103/12,Other,,
1064,875900,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 103/12,Other,,
1065,875901,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 103/12,Other,,
1066,875902,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 103/12,Other,,
1067,875903,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 103/12,Other,,
1068,875904,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 103/12,Other,,
1069,875905,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 103/12,Other,,
1070,875906,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 103/12,Other,,
1071,875907,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 103/12,Other,,
1072,875908,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 103/12,Other,,
1073,875909,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 103/12,Other,,
1074,875910,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 103/13,Other,,
1075,875911,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 103/13,Other,,
1076,875912,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 103/13,Other,,
1077,875913,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 103/13,Other,,
1078,875914,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 103/13,Other,,
1079,875915,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 103/13,Other,,
1080,875916,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 103/13,Other,,
1081,875917,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 103/13,Other,,
1082,875918,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 103/13,Other,,
1083,875919,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 103/13,Other,,
1084,875920,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 103/13,Other,,
1085,875921,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 103/13,Other,,
1086,875922,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 103/13,Other,,
1087,875923,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 103/13,Other,,
1088,875924,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 103/13,Other,,
1089,875925,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 103/13,Other,,
1090,875926,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 103/13,Other,,
1091,875927,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 103/13,Other,,
1092,876755,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 102/14,Other,,
1093,876756,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 102/14,Other,,
1094,876757,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 102/14,Other,,
1095,876758,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 102/14,Other,,
1096,876759,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 102/14,Other,,
1097,876760,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 102/14,Other,,
1098,876761,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 102/14,Other,,
1099,876762,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 102/14,Other,,
1100,876763,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 102/15,Other,,
1101,876764,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 102/15,Other,,
1102,876765,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 102/15,Other,,
1103,876766,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 102/15,Other,,
1104,876767,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 102/15,Other,,
1105,876768,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 102/15,Other,,
1106,876769,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 102/15,Other,,
1107,876770,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 102/15,Other,,
1108,876771,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 102/15,Other,,
1109,876772,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 102/15,Other,,
1110,876773,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 102/15,Other,,
1111,876774,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 102/15,Other,,
1112,876775,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 102/15,Other,,
1113,876776,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 102/15,Other,,
1114,876777,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 102/15,Other,,
1115,876778,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 102/15,Other,,
1116,876779,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 102/15,Other,,
1117,876780,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 102/15,Other,,
1118,876781,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 102/15,Other,,
1119,876782,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 102/15,Other,,
1120,876783,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 102/15,Other,,
1121,876784,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 102/16,Other,,
1122,876785,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 102/16,Other,,
1123,876786,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 102/16,Other,,
1124,876787,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 102/16,Other,,
1125,876788,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 102/16,Other,,
1126,876789,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 102/16,Other,,
1127,876790,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 102/16,Other,,
1128,876791,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 102/16,Other,,
1129,876792,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 102/16,Other,,
1130,876793,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 102/16,Other,,
1131,876794,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 102/16,Other,,
1132,876795,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 102/16,Other,,
1133,877479,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 102/16,Other,,
1134,877480,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 102/16,Other,,
1135,877481,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 102/16,Other,,
1136,877482,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 102/16,Other,,
1137,877483,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 102/16,Other,,
1138,877484,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 102/16,Other,,
1139,877485,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 102/16,Other,,
1140,878038,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 102/16,Other,,
1141,878039,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 102/16,Other,,
1142,878040,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 103/5,Other,,
1143,878041,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 103/5,Other,,
1144,878042,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 103/5,Other,,
1145,878043,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 103/5,Other,,
1146,878044,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 103/5,Other,,
1147,878045,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 103/5,Other,,
1148,878046,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 103/5,Other,,
1149,878047,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 103/5,Other,,
1150,878048,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 103/5,Other,,
1151,878049,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 103/5,Other,,
1152,878050,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 103/5,Other,,
1153,878051,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 103/5,Other,,
1154,878052,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 103/5,Other,,
1155,878053,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 103/5,Other,,
1156,878054,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 103/5,Other,,
1157,878055,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 103/5,Other,,
1158,878056,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 103/5,Other,,
1159,878057,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 103/5,Other,,
1160,878058,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 103/5,Other,,
1161,878059,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 103/5,Other,,
1162,878060,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 103/5,Other,,
1163,878061,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 103/6,Other,,
1164,878062,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 103/6,Other,,
1165,878063,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 103/6,Other,,
1166,878064,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 103/6,Other,,
1167,878065,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 103/6,Other,,
1168,878066,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 103/6,Other,,
1169,878750,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 103/6,Other,,
1170,878751,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 103/6,Other,,
1171,878752,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 103/6,Other,,
1172,878753,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 103/6,Other,,
1173,878754,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 103/6,Other,,
1174,878755,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 103/6,Other,,
1175,878756,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 103/6,Other,,
1176,878757,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 103/6,Other,,
1177,878758,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 103/6,Other,,
1178,878759,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 103/6,Other,,
1179,878760,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 103/6,Other,,
1180,878761,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 103/6,Other,,
1181,878762,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 103/6,Other,,
1182,878763,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 103/6,Other,,
1183,878764,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 103/6,Other,,
1184,878765,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 103/7,Other,,
1185,878766,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 103/7,Other,,
1186,878767,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 103/7,Other,,
1187,878800,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 103/13,Other,,
1188,878801,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 103/13,Other,,
1189,878802,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 103/13,Other,,
1190,878803,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 103/14,Other,,
1191,878804,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 103/14,Other,,
1192,878805,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 103/14,Other,,
1193,878806,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 103/14,Other,,
1194,878807,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 103/14,Other,,
1195,878808,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 103/14,Other,,
1196,878809,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 103/14,Other,,
1197,878810,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 103/14,Other,,
1198,878811,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 103/14,Other,,
1199,878812,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 103/14,Other,,
1200,878813,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 103/14,Other,,
1201,878814,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 103/14,Other,,
1202,878815,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 103/14,Other,,
1203,878816,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 103/14,Other,,
1204,878817,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 103/14,Other,,
1205,878818,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 103/14,Other,,
1206,878819,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 103/14,Other,,
1207,878820,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 103/14,Other,,
1208,878821,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 103/14,Other,,
1209,878822,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 103/14,Other,,
1210,878823,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 103/14,Other,,
1211,878824,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 103/15,Other,,
1212,878825,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 103/15,Other,,
1213,878826,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 103/15,Other,,
1214,878827,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 103/15,Other,,
1215,878828,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 103/15,Other,,
1216,878829,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 103/15,Other,,
1217,878830,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 103/15,Other,,
1218,878831,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 103/15,Other,,
1219,878832,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 103/15,Other,,
1220,878833,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 103/15,Other,,
1221,878834,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 103/15,Other,,
1222,878835,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 103/15,Other,,
1223,878836,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 103/15,Other,,
1224,878837,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 103/15,Other,,
1225,878838,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 103/15,Other,,
1226,878839,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 103/15,Other,,
1227,878840,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 103/15,Other,,
1228,878912,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 102/7,Other,,
1229,878913,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 102/7,Other,,
1230,878914,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 102/7,Other,,
1231,878915,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 102/7,Other,,
1232,878916,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 102/7,Other,,
1233,878917,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 102/8,Other,,
1234,878918,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 102/8,Other,,
1235,878919,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 102/8,Other,,
1236,878920,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 102/8,Other,,
1237,878921,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 102/8,Other,,
1238,878922,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 102/8,Other,,
1239,878923,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 102/8,Other,,
1240,878924,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 102/8,Other,,
1241,878925,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 102/8,Other,,
1242,878926,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 102/8,Other,,
1243,878927,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 102/8,Other,,
1244,878928,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 102/8,Other,,
1245,878929,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 102/8,Other,,
1246,878930,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 102/8,Other,,
1247,878931,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 102/8,Other,,
1248,878932,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 102/8,Other,,
1249,879526,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 103/15,Other,,
1250,879527,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 103/15,Other,,
1251,879528,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 103/15,Other,,
1252,879529,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 103/15,Other,,
1253,879530,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 103/16,Other,,
1254,879531,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 103/16,Other,,
1255,879617,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 102/8,Other,,
1256,879618,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 102/8,Other,,
1257,879619,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 102/8,Other,,
1258,879620,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 102/8,Other,,
1259,879621,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 102/8,Other,,
1260,879622,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 102/9,Other,,
1261,879623,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 102/9,Other,,
1262,879624,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 102/9,Other,,
1263,879625,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 102/9,Other,,
1264,879626,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 102/9,Other,,
1265,879627,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 102/9,Other,,
1266,879628,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 102/9,Other,,
1267,879629,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 102/9,Other,,
1268,879630,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 102/9,Other,,
1269,879631,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 102/9,Other,,
1270,879632,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 102/9,Other,,
1271,879633,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 102/9,Other,,
1272,879634,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 102/9,Other,,
1273,879635,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 102/9,Other,,
1274,879636,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 102/9,Other,,
1275,879637,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 102/9,Other,,
1276,879638,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 102/9,Other,,
1277,879639,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 102/9,Other,,
1278,879640,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 102/9,Other,,
1279,879641,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 102/9,Other,,
1280,879642,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 102/9,Other,,
1281,879643,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 102/10,Other,,
1282,880956,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 103/7,Other,,
1283,880957,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 103/7,Other,,
1284,880958,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 103/7,Other,,
1285,880959,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 103/7,Other,,
1286,880960,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 103/7,Other,,
1287,880961,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 103/7,Other,,
1288,880962,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 103/7,Other,,
1289,880963,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 103/7,Other,,
1290,880964,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 103/7,Other,,
1291,880965,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 103/7,Other,,
1292,880966,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 103/7,Other,,
1293,880967,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 103/7,Other,,
1294,880968,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 103/7,Other,,
1295,880969,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 103/7,Other,,
1296,880970,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 103/7,Other,,
1297,880971,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 103/7,Other,,
1298,880972,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 103/7,Other,,
1299,880973,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 103/7,Other,,
1300,880974,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 103/8,Other,,
1301,880975,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 103/8,Other,,
1302,880976,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 103/8,Other,,
1303,881662,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 103/8,Other,,
1304,881663,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 103/8,Other,,
1305,881664,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 103/8,Other,,
1306,881665,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 103/8,Other,,
1307,881666,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 103/8,Other,,
1308,881667,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 103/8,Other,,
1309,881668,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 103/8,Other,,
1310,881669,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 103/8,Other,,
1311,881670,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 103/8,Other,,
1312,881671,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 103/8,Other,,
1313,881672,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 103/8,Other,,
1314,881673,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 103/8,Other,,
1315,881674,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 103/8,Other,,
1316,881675,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 103/8,Other,,
1317,881676,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 103/8,Other,,
1318,881677,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 103/8,Other,,
1319,881678,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 103/8,Other,,
1320,881679,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 103/8,Other,,
1321,881680,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 103/9,Other,,
1322,881681,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 103/9,Other,,
1323,881682,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 103/9,Other,,
1324,881683,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 103/9,Other,,
1325,881684,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 103/9,Other,,
1326,881685,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 103/9,Other,,
1327,881686,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 103/9,Other,,
1328,881687,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 103/9,Other,,
1329,881720,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 103/16,Other,,
1330,881721,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 103/16,Other,,
1331,881722,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 103/16,Other,,
1332,881723,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 103/16,Other,,
1333,881724,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 103/16,Other,,
1334,881725,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 103/16,Other,,
1335,881726,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 103/16,Other,,
1336,881727,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 103/16,Other,,
1337,881728,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 103/16,Other,,
1338,881729,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 103/16,Other,,
1339,881730,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 103/16,Other,,
1340,881731,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 103/16,Other,,
1341,881732,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 103/16,Other,,
1342,881733,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 103/16,Other,,
1343,881734,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 103/16,Other,,
1344,881735,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 103/16,Other,,
1345,881736,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 103/16,Other,,
1346,881737,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 103/16,Other,,
1347,881738,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 103/16,Other,,
1348,881833,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 102/10,Other,,
1349,881834,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 102/10,Other,,
1350,881835,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 102/10,Other,,
1351,881836,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 102/10,Other,,
1352,881837,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 102/10,Other,,
1353,881838,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 102/10,Other,,
1354,881839,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 102/10,Other,,
1355,881840,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 102/10,Other,,
1356,881841,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 102/10,Other,,
1357,881842,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 102/10,Other,,
1358,881843,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 102/10,Other,,
1359,881844,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 102/10,Other,,
1360,882529,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 102/10,Other,,
1361,882530,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 102/10,Other,,
1362,882531,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 102/10,Other,,
1363,882532,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 102/10,Other,,
1364,882533,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 102/10,Other,,
1365,882534,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 102/10,Other,,
1366,882535,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 102/10,Other,,
1367,882536,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 102/10,Other,,
1368,882537,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 102/11,Other,,
1369,882538,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 102/11,Other,,
1370,882539,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 102/11,Other,,
1371,882540,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 102/11,Other,,
1372,882541,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 102/11,Other,,
1373,882542,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 102/11,Other,,
1374,882543,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 102/11,Other,,
1375,882544,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: 102/11,Other,,
1376,882545,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: 102/11,Other,,
1377,882546,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: 102/11,Other,,
1378,882547,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: 102/11,Other,,
1379,882548,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: 102/11,Other,,
1380,882549,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CALCIUM (Calcium); Study_ID: 102/11,Other,,
1381,882550,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: 102/11,Other,,
1382,882551,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: 102/11,Other,,
1383,882552,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: 102/11,Other,,
1384,882553,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALBGLOB (Albumin/Globulin); Study_ID: 102/11,Other,,
1385,882554,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: 102/11,Other,,
1386,882555,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: 102/11,Other,,
1387,882556,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: 102/11,Other,,
1388,882557,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GGT (Gamma Glutamyl Transferase); Study_ID: 102/11,Other,,
1389,882558,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: 102/12,Other,,
1390,882559,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: 102/12,Other,,
1391,882560,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: TRIG (Triglycerides); Study_ID: 102/12,Other,,
1392,882561,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: PHOSLPD (Phospholipid); Study_ID: 102/12,Other,,
1393,882562,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: 102/12,Other,,
1394,882563,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: BILDIR (Direct Bilirubin); Study_ID: 102/12,Other,,
1395,882564,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: 102/12,Other,,
1396,922983,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: BASO (Basophils); Study_ID: S011002,Other,,
1397,922984,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: S011002,Other,,
1398,922985,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: S011002,Other,,
1399,922986,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: S011002,Other,,
1400,922987,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: S011002,Other,,
1401,922988,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: EOS (Eosinophils); Study_ID: S011002,Other,,
1402,922989,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: NEUTSG (Neutrophils, Segmented); Study_ID: S011002",Other,,
1403,922990,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: S011002,Other,,
1404,922991,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: RBCNUC (Nucleated Erythrocytes); Study_ID: S011002,Other,,
1405,922992,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: S011002,Other,,
1406,922993,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: S011002,Other,,
1407,922994,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: LYM (Lymphocytes); Study_ID: S011002,Other,,
1408,922995,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: S011002,Other,,
1409,922996,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MONO (Monocytes); Study_ID: S011002,Other,,
1410,922997,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: S011002,Other,,
1411,922998,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: S011002,Other,,
1412,922999,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: S011002,Other,,
1413,923000,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: S011002,Other,,
1414,923001,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: S011002,Other,,
1415,923002,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: BASO (Basophils); Study_ID: S030120,Other,,
1416,923003,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: NEUTSG (Neutrophils, Segmented); Study_ID: S030120",Other,,
1417,923194,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: S030120,Other,,
1418,923195,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: S030120,Other,,
1419,923196,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: EOS (Eosinophils); Study_ID: S030120,Other,,
1420,923197,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MONO (Monocytes); Study_ID: S030120,Other,,
1421,923198,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: S030120,Other,,
1422,923199,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: RBCNUC (Nucleated Erythrocytes); Study_ID: S030120,Other,,
1423,923200,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: S030120,Other,,
1424,923201,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: S030120,Other,,
1425,923202,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: S030120,Other,,
1426,923203,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: S030120,Other,,
1427,923204,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: S030120,Other,,
1428,923205,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: S030120,Other,,
1429,923206,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: S030120,Other,,
1430,923207,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: LYM (Lymphocytes); Study_ID: S030120,Other,,
1431,923208,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: S030120,Other,,
1432,923209,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: S030120,Other,,
1433,923210,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: S030120,Other,,
1434,926280,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: EOS (Eosinophils); Study_ID: S011002,Other,,
1435,926281,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: RBCNUC (Nucleated Erythrocytes); Study_ID: S011002,Other,,
1436,926282,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: S011002,Other,,
1437,926283,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: S011002,Other,,
1438,926284,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: S011002,Other,,
1439,926285,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: S011002,Other,,
1440,926286,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: S011002,Other,,
1441,926915,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: S011002,Other,,
1442,926916,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MONO (Monocytes); Study_ID: S011002,Other,,
1443,926917,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: S011002,Other,,
1444,926918,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: S011002,Other,,
1445,926919,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: S011002,Other,,
1446,926920,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: NEUTSG (Neutrophils, Segmented); Study_ID: S011002",Other,,
1447,926921,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: S011002,Other,,
1448,926922,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: S011002,Other,,
1449,926923,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: BASO (Basophils); Study_ID: S030120,Other,,
1450,926924,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: NEUTSG (Neutrophils, Segmented); Study_ID: S030120",Other,,
1451,926925,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: S030120,Other,,
1452,926926,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: S030120,Other,,
1453,926927,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: S030120,Other,,
1454,926928,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: S030120,Other,,
1455,926929,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: RBCNUC (Nucleated Erythrocytes); Study_ID: S030120,Other,,
1456,926930,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: EOS (Eosinophils); Study_ID: S030120,Other,,
1457,926931,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: S030120,Other,,
1458,926932,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MONO (Monocytes); Study_ID: S030120,Other,,
1459,926933,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: S030120,Other,,
1460,926934,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: S030120,Other,,
1461,926935,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: LYM (Lymphocytes); Study_ID: S030120,Other,,
1462,926936,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: S030120,Other,,
1463,926937,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: S030120,Other,,
1464,926938,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: S030120,Other,,
1465,926939,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: S030120,Other,,
1466,926940,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: S030120,Other,,
1467,926941,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: S030120,Other,,
1468,934264,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: BASO (Basophils); Study_ID: S011002,Other,,
1469,934265,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: S011002,Other,,
1470,934266,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: S011002,Other,,
1471,934267,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: S011002,Other,,
1472,934268,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: EOS (Eosinophils); Study_ID: S011002,Other,,
1473,934269,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: NEUTSG (Neutrophils, Segmented); Study_ID: S011002",Other,,
1474,934270,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: S011002,Other,,
1475,934271,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: RBCNUC (Nucleated Erythrocytes); Study_ID: S011002,Other,,
1476,934272,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: S011002,Other,,
1477,934273,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: S011002,Other,,
1478,934274,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: S011002,Other,,
1479,934275,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: S011002,Other,,
1480,934276,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: S011002,Other,,
1481,934694,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: BASO (Basophils); Study_ID: S011002,Other,,
1482,934905,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: LYM (Lymphocytes); Study_ID: S011002,Other,,
1483,934906,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MONO (Monocytes); Study_ID: S011002,Other,,
1484,934907,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: S011002,Other,,
1485,934908,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: S011002,Other,,
1486,934909,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: S011002,Other,,
1487,934910,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: S011002,Other,,
1488,934911,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: BASO (Basophils); Study_ID: S011002,Other,,
1489,934912,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: S011002,Other,,
1490,934913,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: S011002,Other,,
1491,934914,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: NEUTSG (Neutrophils, Segmented); Study_ID: S011002",Other,,
1492,934915,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: EOS (Eosinophils); Study_ID: S011002,Other,,
1493,934916,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: LYM (Lymphocytes); Study_ID: S011002,Other,,
1494,934917,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: S011002,Other,,
1495,934918,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: RBCNUC (Nucleated Erythrocytes); Study_ID: S011002,Other,,
1496,934919,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: S011002,Other,,
1497,934920,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MONO (Monocytes); Study_ID: S011002,Other,,
1498,934921,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: S011002,Other,,
1499,934922,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: S011002,Other,,
1500,934923,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: S011002,Other,,
1501,934924,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: S011002,Other,,
1502,934925,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: S011002,Other,,
1503,934926,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: S011002,Other,,
1504,934927,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: S011002,Other,,
1505,934928,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: S011002,Other,,
1506,934929,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: S011002,Other,,
1507,934930,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: BASO (Basophils); Study_ID: S011002,Other,,
1508,934931,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: LYM (Lymphocytes); Study_ID: S011002,Other,,
1509,934932,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: S011002,Other,,
1510,934933,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: S011002,Other,,
1511,935324,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: LYM (Lymphocytes); Study_ID: S011002,Other,,
1512,935325,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: S011002,Other,,
1513,935326,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: RBCNUC (Nucleated Erythrocytes); Study_ID: S011002,Other,,
1514,935327,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: NEUTSG (Neutrophils, Segmented); Study_ID: S011002",Other,,
1515,935328,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: S011002,Other,,
1516,935329,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: EOS (Eosinophils); Study_ID: S011002,Other,,
1517,935330,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: S011002,Other,,
1518,935331,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: S011002,Other,,
1519,935332,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: S011002,Other,,
1520,935333,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MONO (Monocytes); Study_ID: S011002,Other,,
1521,935334,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: S011002,Other,,
1522,935335,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: S011002,Other,,
1523,935336,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: S011002,Other,,
1524,935337,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: S011002,Other,,
1525,935338,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: S011002,Other,,
1526,935339,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: S011002,Other,,
1527,935340,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: S011002,Other,,
1528,935341,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: S011002,Other,,
1529,936908,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: S011002,Other,,
1530,936909,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: S011002,Other,,
1531,936910,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: S011002,Other,,
1532,936911,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: S011002,Other,,
1533,936912,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: S011002,Other,,
1534,936913,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MONO (Monocytes); Study_ID: S011002,Other,,
1535,936914,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: NEUTSG (Neutrophils, Segmented); Study_ID: S011002",Other,,
1536,936915,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: S011002,Other,,
1537,937546,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: LYM (Lymphocytes); Study_ID: S011002,Other,,
1538,937547,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: S011002,Other,,
1539,937548,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: BASO (Basophils); Study_ID: S011002,Other,,
1540,937549,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: S011002,Other,,
1541,937550,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: S011002,Other,,
1542,937551,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: S011002,Other,,
1543,937552,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MONO (Monocytes); Study_ID: S011002,Other,,
1544,937553,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: RBCNUC (Nucleated Erythrocytes); Study_ID: S011002,Other,,
1545,937554,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: LYM (Lymphocytes); Study_ID: S011002,Other,,
1546,937555,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: S011002,Other,,
1547,937556,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: S011002,Other,,
1548,937557,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: EOS (Eosinophils); Study_ID: S011002,Other,,
1549,937558,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: S011002,Other,,
1550,937559,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: S011002,Other,,
1551,937560,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: S011002,Other,,
1552,937561,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: S011002,Other,,
1553,937562,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: S011002,Other,,
1554,937563,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: S011002,Other,,
1555,937564,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: S011002,Other,,
1556,937565,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: S011002,Other,,
1557,937566,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: NEUTSG (Neutrophils, Segmented); Study_ID: S011002",Other,,
1558,945559,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: BASO (Basophils); Study_ID: S011002,Other,,
1559,945560,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: S011002,Other,,
1560,945561,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: LYM (Lymphocytes); Study_ID: S011002,Other,,
1561,945562,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: WBC (Leukocytes); Study_ID: S011002,Other,,
1562,945563,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: S011002,Other,,
1563,945564,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: RBCNUC (Nucleated Erythrocytes); Study_ID: S011002,Other,,
1564,945565,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: S011002,Other,,
1565,945566,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: S011002,Other,,
1566,945567,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: HCT (Hematocrit); Study_ID: S011002,Other,,
1567,945568,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: EOS (Eosinophils); Study_ID: S011002,Other,,
1568,945569,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: BASOLE (Basophils/Leukocytes); Study_ID: S011002,Other,,
1569,945570,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: S011002,Other,,
1570,945571,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCHC (Ery. Mean Corpuscular HGB Concentration); Study_ID: S011002,Other,,
1571,945572,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MONO (Monocytes); Study_ID: S011002,Other,,
1572,945573,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: NEUTSG (Neutrophils, Segmented); Study_ID: S011002",Other,,
1573,945574,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: EOSLE (Eosinophils/Leukocytes); Study_ID: S011002,Other,,
1574,945575,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCV (Ery. Mean Corpuscular Volume); Study_ID: S011002,Other,,
1575,945576,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: S011002,Other,,
1576,945577,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: PLAT (Platelets); Study_ID: S011002,Other,,
1577,945578,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: BASO (Basophils); Study_ID: S011002,Other,,
1578,945579,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MCH (Ery. Mean Corpuscular Hemoglobin); Study_ID: S011002,Other,,
1579,945580,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: NEUTLE (Neutrophils/Leukocytes); Study_ID: S011002,Other,,
1580,945581,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: RBC (Erythrocytes); Study_ID: S011002,Other,,
1581,945582,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: HGB (Hemoglobin); Study_ID: S011002,Other,,
1582,945583,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: MONOLE (Monocytes/Leukocytes); Study_ID: S011002,Other,,
1583,945584,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: EOS (Eosinophils); Study_ID: S011002,Other,,
1584,945585,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: LYMLE (Lymphocytes/Leukocytes); Study_ID: S011002,Other,,
1585,945586,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Hematology; Assay: RBCNUC (Nucleated Erythrocytes); Study_ID: S011002,Other,,
1586,950530,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: S011002,Other,,
1587,950531,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CK (Creatine Kinase); Study_ID: S011002,Other,,
1588,950532,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: S011002,Other,,
1589,951162,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: LIPASE (Triacylglycerol Lipase); Study_ID: S011002,Other,,
1590,951163,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: S011002,Other,,
1591,951164,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CO2 (Carbon Dioxide); Study_ID: S011002,Other,,
1592,951165,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: S011002,Other,,
1593,951166,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: S011002,Other,,
1594,951167,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: URATE (Urate); Study_ID: S011002,Other,,
1595,951168,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: S011002,Other,,
1596,951169,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: S011002,Other,,
1597,951170,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: S011002,Other,,
1598,951171,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: S011002,Other,,
1599,951172,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: S011002,Other,,
1600,951173,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: S011002,Other,,
1601,951174,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: S011002,Other,,
1602,951175,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: S011002,Other,,
1603,951176,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: S011002,Other,,
1604,951177,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: S011002,Other,,
1605,951178,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: S011002,Other,,
1606,951179,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: S011002,Other,,
1607,951180,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: S011002,Other,,
1608,951181,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: S011002,Other,,
1609,951182,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CO2 (Carbon Dioxide); Study_ID: S011002,Other,,
1610,951183,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CK (Creatine Kinase); Study_ID: S011002,Other,,
1611,951184,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: S011002,Other,,
1612,951185,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: S011002,Other,,
1613,951186,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: S011002,Other,,
1614,951187,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: URATE (Urate); Study_ID: S011002,Other,,
1615,951188,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: S011002,Other,,
1616,951189,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: LIPASE (Triacylglycerol Lipase); Study_ID: S011002,Other,,
1617,951190,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: S011002,Other,,
1618,951191,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: S011002,Other,,
1619,951192,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: S011002,Other,,
1620,951193,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: S011002,Other,,
1621,953331,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: S011002,Other,,
1622,953332,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: S011002,Other,,
1623,953333,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: URATE (Urate); Study_ID: S011002,Other,,
1624,953334,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: S011002,Other,,
1625,953335,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: S011002,Other,,
1626,953336,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: S011002,Other,,
1627,953337,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: S011002,Other,,
1628,953338,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: S011002,Other,,
1629,953339,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CO2 (Carbon Dioxide); Study_ID: S011002,Other,,
1630,953340,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: S011002,Other,,
1631,953341,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: S011002,Other,,
1632,953342,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: LIPASE (Triacylglycerol Lipase); Study_ID: S011002,Other,,
1633,953343,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: S011002,Other,,
1634,955871,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: S011002,Other,,
1635,955872,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: S011002,Other,,
1636,955873,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CK (Creatine Kinase); Study_ID: S011002,Other,,
1637,955874,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: S011002,Other,,
1638,955875,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: S011002,Other,,
1639,955876,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: S011002,Other,,
1640,955877,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: S030120,Other,,
1641,955878,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: S030120,Other,,
1642,955879,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: S030120,Other,,
1643,955880,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: S030120,Other,,
1644,955881,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: S030120,Other,,
1645,955882,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CK (Creatine Kinase); Study_ID: S030120,Other,,
1646,955883,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: S030120,Other,,
1647,955884,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: S030120,Other,,
1648,955885,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: S030120,Other,,
1649,955886,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: S030120,Other,,
1650,955887,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: S030120,Other,,
1651,955888,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: S030120,Other,,
1652,955889,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: S030120,Other,,
1653,955890,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CO2 (Carbon Dioxide); Study_ID: S030120,Other,,
1654,955891,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: LIPASE (Triacylglycerol Lipase); Study_ID: S030120,Other,,
1655,955892,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: S030120,Other,,
1656,955893,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: S030120,Other,,
1657,955894,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: S030120,Other,,
1658,955895,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: URATE (Urate); Study_ID: S030120,Other,,
1659,958852,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: S011002,Other,,
1660,958853,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CO2 (Carbon Dioxide); Study_ID: S011002,Other,,
1661,958854,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: S011002,Other,,
1662,958855,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: LIPASE (Triacylglycerol Lipase); Study_ID: S011002,Other,,
1663,958856,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: S011002,Other,,
1664,958857,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: URATE (Urate); Study_ID: S011002,Other,,
1665,958858,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: S011002,Other,,
1666,958859,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: S011002,Other,,
1667,958860,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: S011002,Other,,
1668,958861,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: S011002,Other,,
1669,958862,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: S011002,Other,,
1670,958863,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: S011002,Other,,
1671,958864,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: S011002,Other,,
1672,958865,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: S011002,Other,,
1673,958866,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CK (Creatine Kinase); Study_ID: S011002,Other,,
1674,958867,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: S011002,Other,,
1675,958868,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: S011002,Other,,
1676,958869,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: S011002,Other,,
1677,961304,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: LIPASE (Triacylglycerol Lipase); Study_ID: S030120,Other,,
1678,961305,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: S030120,Other,,
1679,961306,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: S030120,Other,,
1680,961307,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: S030120,Other,,
1681,965752,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: S011002,Other,,
1682,965753,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: S011002,Other,,
1683,965754,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: S011002,Other,,
1684,965755,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: S011002,Other,,
1685,967291,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: S011002,Other,,
1686,967292,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: S011002,Other,,
1687,967293,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: S011002,Other,,
1688,967294,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: S011002,Other,,
1689,967295,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CK (Creatine Kinase); Study_ID: S011002,Other,,
1690,967296,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: S011002,Other,,
1691,967297,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: S011002,Other,,
1692,967298,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: S011002,Other,,
1693,967299,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: S011002,Other,,
1694,967300,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: LIPASE (Triacylglycerol Lipase); Study_ID: S011002,Other,,
1695,967301,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: S011002,Other,,
1696,967302,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: S011002,Other,,
1697,967303,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: S011002,Other,,
1698,967304,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: S011002,Other,,
1699,967305,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: S011002,Other,,
1700,967971,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: S011002,Other,,
1701,967972,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CK (Creatine Kinase); Study_ID: S030120,Other,,
1702,967973,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: S030120,Other,,
1703,967974,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: S030120,Other,,
1704,967975,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: S030120,Other,,
1705,967976,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: S030120,Other,,
1706,967977,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: S030120,Other,,
1707,968608,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CO2 (Carbon Dioxide); Study_ID: S030120,Other,,
1708,968609,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: S030120,Other,,
1709,968610,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: S030120,Other,,
1710,968611,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: S030120,Other,,
1711,968612,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: S030120,Other,,
1712,968613,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: URATE (Urate); Study_ID: S030120,Other,,
1713,968614,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: S030120,Other,,
1714,968615,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: S030120,Other,,
1715,968616,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: S030120,Other,,
1716,969954,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: S011002,Other,,
1717,969955,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: URATE (Urate); Study_ID: S011002,Other,,
1718,969956,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: S011002,Other,,
1719,969957,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CO2 (Carbon Dioxide); Study_ID: S011002,Other,,
1720,969958,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CK (Creatine Kinase); Study_ID: S011002,Other,,
1721,969959,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: S011002,Other,,
1722,969960,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: S011002,Other,,
1723,969961,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: S011002,Other,,
1724,969962,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: S011002,Other,,
1725,969963,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: S011002,Other,,
1726,969964,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: S011002,Other,,
1727,969965,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: S011002,Other,,
1728,969966,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: S011002,Other,,
1729,969967,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: S011002,Other,,
1730,969968,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: S011002,Other,,
1731,969969,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: S011002,Other,,
1732,969970,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: S011002,Other,,
1733,969971,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CK (Creatine Kinase); Study_ID: S011002,Other,,
1734,969972,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: S011002,Other,,
1735,969973,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: S011002,Other,,
1736,969974,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: URATE (Urate); Study_ID: S011002,Other,,
1737,969975,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CO2 (Carbon Dioxide); Study_ID: S011002,Other,,
1738,969976,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: S011002,Other,,
1739,969977,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: S011002,Other,,
1740,969978,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: LIPASE (Triacylglycerol Lipase); Study_ID: S011002,Other,,
1741,969979,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: S011002,Other,,
1742,969980,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: S011002,Other,,
1743,969981,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: S011002,Other,,
1744,969982,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: S011002,Other,,
1745,974205,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALB (Albumin); Study_ID: S011002,Other,,
1746,974206,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CO2 (Carbon Dioxide); Study_ID: S011002,Other,,
1747,974207,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: S011002,Other,,
1748,974208,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALT (Alanine Aminotransferase); Study_ID: S011002,Other,,
1749,974209,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: S011002,Other,,
1750,974210,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CK (Creatine Kinase); Study_ID: S011002,Other,,
1751,974211,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: S011002,Other,,
1752,974212,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: S011002,Other,,
1753,974213,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: SODIUM (Sodium); Study_ID: S011002,Other,,
1754,974214,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: PROT (Protein); Study_ID: S011002,Other,,
1755,974215,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: S011002,Other,,
1756,974216,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: PHOS (Phosphate); Study_ID: S011002,Other,,
1757,974217,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: S011002,Other,,
1758,974218,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: URATE (Urate); Study_ID: S011002,Other,,
1759,974219,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: S011002,Other,,
1760,974220,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: LIPASE (Triacylglycerol Lipase); Study_ID: S011002,Other,,
1761,975972,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: LIPASE (Triacylglycerol Lipase); Study_ID: S011002,Other,,
1762,975973,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CHOL (Cholesterol); Study_ID: S011002,Other,,
1763,975974,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: GLUC (Glucose); Study_ID: S011002,Other,,
1764,975975,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: ALP (Alkaline Phosphatase); Study_ID: S011002,Other,,
1765,975976,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CO2 (Carbon Dioxide); Study_ID: S011002,Other,,
1766,975977,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: S011002,Other,,
1767,975978,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: URATE (Urate); Study_ID: S011002,Other,,
1768,975979,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: AST (Aspartate Aminotransferase); Study_ID: S011002,Other,,
1769,975980,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: S011002,Other,,
1770,975981,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CHLORIDE (Chloride); Study_ID: S011002,Other,,
1771,975982,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: CREAT (Creatinine); Study_ID: S011002,Other,,
1772,975983,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 0.25 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: POTASSIUM (Potassium); Study_ID: S011002,Other,,
1773,976243,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: BILI (Bilirubin); Study_ID: S011002,Other,,
1774,976244,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: LDH (Lactate Dehydrogenase); Study_ID: S011002,Other,,
1775,976245,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Biochemistry; Assay: BUN (Blood Urea Nitrogen); Study_ID: S011002,Other,,
1776,978018,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Hypertrophy; Study_ID: S030120",Other,,
1777,978019,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Lipid Accumulation, Macrovesicular; Study_ID: S030120",Other,,
1778,978020,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S030120",Other,,
1779,978021,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Fibrosis; Study_ID: S030120",Other,,
1780,978022,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Nuclear Cytoplasmic Condensation; Study_ID: S030120,Other,,
1781,978023,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Lipid Accumulation, Microvesicular; Study_ID: S030120",Other,,
1782,978024,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Necrosis, Oncocytic; Study_ID: S030120",Other,,
1783,978025,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Multinucleated; Study_ID: S030120",Other,,
1784,978026,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Malignant Lymphoma; Study_ID: S030120,Other,,
1785,978027,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S030120",Other,,
1786,978028,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Neutrophilic; Study_ID: S030120",Other,,
1787,978029,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Capsule, Mesothelial Cell, Hyperplasia; Study_ID: S030120",Other,,
1788,978030,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Degeneration; Study_ID: S030120",Other,,
1789,978031,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Necrosis, Oncocytic; Study_ID: S030120",Other,,
1790,978032,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Lipid Accumulation, Microvesicular; Study_ID: S030120",Other,,
1791,978033,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Oval Cell, Hyperplasia; Study_ID: S030120",Other,,
1792,978034,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Subcapsular, Fibrosis; Study_ID: S030120",Other,,
1793,978035,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Capsule, Thrombus; Study_ID: S030120",Other,,
1794,978036,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Clear Cell Focus; Study_ID: S030120,Other,,
1795,978037,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Cytoplasm, Eosinophilia; Study_ID: S030120",Other,,
1796,978038,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Glycogen Accumulation; Study_ID: S030120",Other,,
1797,978039,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Granulomatous; Study_ID: S030120",Other,,
1798,978040,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Autolysis; Study_ID: S030120,Other,,
1799,978041,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Bile Duct, Necrosis, Oncocytic; Study_ID: S030120",Other,,
1800,978042,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Glycogen Accumulation; Study_ID: S030120",Other,,
1801,978043,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Lipid Accumulation, Macrovesicular; Study_ID: S030120",Other,,
1802,978044,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Necrosis, Oncocytic; Study_ID: S030120",Other,,
1803,978045,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Necrosis, Oncocytic; Study_ID: S030120",Other,,
1804,978046,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Edema; Study_ID: S030120",Other,,
1805,984508,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Kidney; Assay: Autolysis; Study_ID: S011002,Other,,
1806,984509,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S011002",Other,,
1807,984510,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Diffuse, Hypertrophy; Study_ID: S011002",Other,,
1808,984511,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Erythrophagocytosis; Study_ID: S011002",Other,,
1809,984512,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Glycogen Accumulation; Study_ID: S011002",Other,,
1810,984513,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Subcapsular, Necrosis, Oncocytic; Study_ID: S011002",Other,,
1811,984514,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S011002",Other,,
1812,984515,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Kidney; Assay: Infiltrative Cell, Polymorphonuclear Cell; Study_ID: S011002",Other,,
1813,984516,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Kidney; Assay: Infiltrative Cell, Mononuclear Cell; Study_ID: S011002",Other,,
1814,984517,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Kidney; Assay: Cortex, Mineralization; Study_ID: S011002",Other,,
1815,984518,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Kidney; Assay: Papilla, Tubule, Regeneration; Study_ID: S011002",Other,,
1816,984519,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Bile Duct Dilatation; Study_ID: S011002,Other,,
1817,984520,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Capsule, Mesothelial Cell, Hyperplasia; Study_ID: S011002",Other,,
1818,984521,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular Fibrosis; Study_ID: S011002,Other,,
1819,984522,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Atrophy; Study_ID: S011002",Other,,
1820,984523,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Cytoplasm, Eosinophilia; Study_ID: S011002",Other,,
1821,984524,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Degeneration; Study_ID: S011002",Other,,
1822,984525,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Mineralization; Study_ID: S011002",Other,,
1823,984526,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Necrosis, Oncocytic; Study_ID: S011002",Other,,
1824,984527,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Glycogen Accumulation; Study_ID: S011002",Other,,
1825,984528,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Necrosis, Apoptotic; Study_ID: S011002",Other,,
1826,984529,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Subcapsular, Mineralization; Study_ID: S011002",Other,,
1827,984530,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Extramedullary Hematopoiesis; Study_ID: S011002",Other,,
1828,984531,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S011002",Other,,
1829,984532,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Kidney; Assay: Medulla, Tubule, Dilatation; Study_ID: S011002",Other,,
1830,984533,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Kidney; Assay: Nephropathy; Study_ID: S011002,Other,,
1831,984534,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S011002",Other,,
1832,984535,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Necrosis, Apoptotic; Study_ID: S011002",Other,,
1833,984536,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Diffuse, Cytoplasm, Eosinophilia; Study_ID: S011002",Other,,
1834,984537,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Lipid Accumulation, Macrovesicular; Study_ID: S011002",Other,,
1835,984538,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Lipid Accumulation, Microvesicular; Study_ID: S011002",Other,,
1836,984539,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Necrosis, Apoptotic; Study_ID: S011002",Other,,
1837,984540,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Increased Mitoses; Study_ID: S011002",Other,,
1838,984541,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Lipid Accumulation, Microvesicular; Study_ID: S011002",Other,,
1839,984542,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Hypertrophy; Study_ID: S011002",Other,,
1840,984543,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Lipid Accumulation, Macrovesicular; Study_ID: S011002",Other,,
1841,984544,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Kidney; Assay: Interstitium, Inflammation, Chronic; Study_ID: S011002",Other,,
1842,985012,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Kidney; Assay: Medulla, Mineralization; Study_ID: S011002",Other,,
1843,985013,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Kidney; Assay: Papilla, Necrosis; Study_ID: S011002",Other,,
1844,985014,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Single Hepatocyte Necrosis; Study_ID: S011002,Other,,
1845,985015,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Bile Duct Hyperplasia; Study_ID: S011002,Other,,
1846,985016,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Hypertrophy; Study_ID: S011002",Other,,
1847,985017,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Lipid Accumulation, Macrovesicular; Study_ID: S011002",Other,,
1848,985018,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S011002",Other,,
1849,985019,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Fibrosis; Study_ID: S011002",Other,,
1850,985020,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Kidney; Assay: Cortex, Tubule, Vacuolation; Study_ID: S011002",Other,,
1851,985021,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Kidney; Assay: Interstitium, Fibrosis; Study_ID: S011002",Other,,
1852,985022,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Kidney; Assay: Papilla, Mineralization; Study_ID: S011002",Other,,
1853,985023,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Kidney; Assay: Papilla, Cyst(S); Study_ID: S011002",Other,,
1854,985024,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Nuclear Cytoplasmic Condensation; Study_ID: S011002,Other,,
1855,985025,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Kidney; Assay: Cortex, Tubule, Dilatation; Study_ID: S011002",Other,,
1856,985026,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Capsule, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S011002",Other,,
1857,985027,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Lipid Accumulation, Microvesicular; Study_ID: S011002",Other,,
1858,985028,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Necrosis, Oncocytic; Study_ID: S011002",Other,,
1859,985029,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Multinucleated; Study_ID: S011002",Other,,
1860,985030,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Malignant Lymphoma; Study_ID: S011002,Other,,
1861,985031,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S011002",Other,,
1862,985032,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Neutrophilic; Study_ID: S011002",Other,,
1863,985033,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Kidney; Assay: Pelvis, Inflammation, Subacute; Study_ID: S011002",Other,,
1864,985034,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Kidney; Assay: Pelvis, Urothelial Hyperplasia; Study_ID: S011002",Other,,
1865,985035,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Kidney; Assay: Tubule, Regeneration; Study_ID: S011002",Other,,
1866,985036,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Degeneration; Study_ID: S011002",Other,,
1867,985037,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Lipid Accumulation, Microvesicular; Study_ID: S011002",Other,,
1868,985038,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Oval Cell, Hyperplasia; Study_ID: S011002",Other,,
1869,985039,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Subcapsular, Fibrosis; Study_ID: S011002",Other,,
1870,985040,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Kidney; Assay: Tubule, Deposit; Study_ID: S011002",Other,,
1871,985041,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Kidney; Assay: Pelvis, Dilatation; Study_ID: S011002",Other,,
1872,985042,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Kidney; Assay: Tubule, Hyaline Droplets; Study_ID: S011002",Other,,
1873,985043,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Kidney; Assay: Cortex, Tubule, Necrosis; Study_ID: S011002",Other,,
1874,985044,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Kidney; Assay: Cortex, Cyst(S); Study_ID: S011002",Other,,
1875,985045,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Capsule, Thrombus; Study_ID: S011002",Other,,
1876,985046,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Clear Cell Focus; Study_ID: S011002,Other,,
1877,985047,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Necrosis, Apoptotic; Study_ID: S011002",Other,,
1878,985048,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Cytoplasm, Eosinophilia; Study_ID: S011002",Other,,
1879,985049,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Granulomatous; Study_ID: S011002",Other,,
1880,985050,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Kidney; Assay: Medulla, Cyst(S); Study_ID: S011002",Other,,
1881,985517,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Autolysis; Study_ID: S011002,Other,,
1882,985518,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Bile Duct, Necrosis, Oncocytic; Study_ID: S011002",Other,,
1883,985519,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Glycogen Accumulation; Study_ID: S011002",Other,,
1884,985520,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Lipid Accumulation, Macrovesicular; Study_ID: S011002",Other,,
1885,985521,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Necrosis, Oncocytic; Study_ID: S011002",Other,,
1886,985522,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Necrosis, Oncocytic; Study_ID: S011002",Other,,
1887,985523,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Edema; Study_ID: S011002",Other,,
1888,985524,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: M1; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Kidney; Assay: Tubule, Cast, Proteinaceous; Study_ID: S011002",Other,,
1889,985525,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S030120",Other,,
1890,985526,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Diffuse, Hypertrophy; Study_ID: S030120",Other,,
1891,985527,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Erythrophagocytosis; Study_ID: S030120",Other,,
1892,985528,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Glycogen Accumulation; Study_ID: S030120",Other,,
1893,985529,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Subcapsular, Necrosis, Oncocytic; Study_ID: S030120",Other,,
1894,985530,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S030120",Other,,
1895,985531,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Bile Duct Dilatation; Study_ID: S030120,Other,,
1896,985532,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular Fibrosis; Study_ID: S030120,Other,,
1897,985533,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Atrophy; Study_ID: S030120",Other,,
1898,985534,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Cytoplasm, Eosinophilia; Study_ID: S030120",Other,,
1899,985535,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Degeneration; Study_ID: S030120",Other,,
1900,985536,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Mineralization; Study_ID: S030120",Other,,
1901,985537,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Necrosis, Apoptotic; Study_ID: S030120",Other,,
1902,985538,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Subcapsular, Mineralization; Study_ID: S030120",Other,,
1903,985539,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Extramedullary Hematopoiesis; Study_ID: S030120",Other,,
1904,985540,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S030120",Other,,
1905,985541,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S030120",Other,,
1906,985542,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Necrosis, Apoptotic; Study_ID: S030120",Other,,
1907,985543,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Diffuse, Cytoplasm, Eosinophilia; Study_ID: S030120",Other,,
1908,985544,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Lipid Accumulation, Macrovesicular; Study_ID: S030120",Other,,
1909,985545,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Lipid Accumulation, Microvesicular; Study_ID: S030120",Other,,
1910,985546,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Necrosis, Apoptotic; Study_ID: S030120",Other,,
1911,985547,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Increased Mitoses; Study_ID: S030120",Other,,
1912,985548,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Lipid Accumulation, Microvesicular; Study_ID: S030120",Other,,
1913,985549,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Necrosis, Apoptotic; Study_ID: S030120",Other,,
1914,985550,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Hypertrophy; Study_ID: S030120",Other,,
1915,985551,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Lipid Accumulation, Macrovesicular; Study_ID: S030120",Other,,
1916,985552,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Single Hepatocyte Necrosis; Study_ID: S030120,Other,,
1917,985553,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Bile Duct Hyperplasia; Study_ID: S030120,Other,,
1918,985554,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Capsule, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S030120",Other,,
1919,986144,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Mineralization; Study_ID: S011002",Other,,
1920,986145,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Necrosis, Oncocytic; Study_ID: S011002",Other,,
1921,986146,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Necrosis, Apoptotic; Study_ID: S011002",Other,,
1922,986147,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Subcapsular, Mineralization; Study_ID: S011002",Other,,
1923,986148,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Extramedullary Hematopoiesis; Study_ID: S011002",Other,,
1924,986149,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S011002",Other,,
1925,986150,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S011002",Other,,
1926,986151,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S011002",Other,,
1927,986152,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Necrosis, Apoptotic; Study_ID: S011002",Other,,
1928,986153,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Diffuse, Cytoplasm, Eosinophilia; Study_ID: S011002",Other,,
1929,986154,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Lipid Accumulation, Macrovesicular; Study_ID: S011002",Other,,
1930,986155,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Lipid Accumulation, Microvesicular; Study_ID: S011002",Other,,
1931,986156,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Necrosis, Apoptotic; Study_ID: S011002",Other,,
1932,986157,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Increased Mitoses; Study_ID: S011002",Other,,
1933,986158,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Lipid Accumulation, Microvesicular; Study_ID: S011002",Other,,
1934,986159,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Hypertrophy; Study_ID: S011002",Other,,
1935,986160,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Lipid Accumulation, Macrovesicular; Study_ID: S011002",Other,,
1936,986161,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Single Hepatocyte Necrosis; Study_ID: S011002,Other,,
1937,986162,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Bile Duct Hyperplasia; Study_ID: S011002,Other,,
1938,986163,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Hypertrophy; Study_ID: S011002",Other,,
1939,986164,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Lipid Accumulation, Macrovesicular; Study_ID: S011002",Other,,
1940,986165,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Fibrosis; Study_ID: S011002",Other,,
1941,986166,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Nuclear Cytoplasmic Condensation; Study_ID: S011002,Other,,
1942,986167,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Capsule, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S011002",Other,,
1943,986168,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Lipid Accumulation, Microvesicular; Study_ID: S011002",Other,,
1944,986169,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Necrosis, Oncocytic; Study_ID: S011002",Other,,
1945,986170,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Multinucleated; Study_ID: S011002",Other,,
1946,986171,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Malignant Lymphoma; Study_ID: S011002,Other,,
1947,986172,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S011002",Other,,
1948,986173,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Neutrophilic; Study_ID: S011002",Other,,
1949,986174,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Degeneration; Study_ID: S011002",Other,,
1950,986756,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Lipid Accumulation, Microvesicular; Study_ID: S011002",Other,,
1951,986757,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Oval Cell, Hyperplasia; Study_ID: S011002",Other,,
1952,986758,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Subcapsular, Fibrosis; Study_ID: S011002",Other,,
1953,986759,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Capsule, Thrombus; Study_ID: S011002",Other,,
1954,986760,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Clear Cell Focus; Study_ID: S011002,Other,,
1955,986761,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Necrosis, Apoptotic; Study_ID: S011002",Other,,
1956,986762,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Cytoplasm, Eosinophilia; Study_ID: S011002",Other,,
1957,986763,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Glycogen Accumulation; Study_ID: S011002",Other,,
1958,988629,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Granulomatous; Study_ID: S011002",Other,,
1959,988630,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Autolysis; Study_ID: S011002,Other,,
1960,988631,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Bile Duct, Necrosis, Oncocytic; Study_ID: S011002",Other,,
1961,988632,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Glycogen Accumulation; Study_ID: S011002",Other,,
1962,988633,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Lipid Accumulation, Macrovesicular; Study_ID: S011002",Other,,
1963,988634,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Necrosis, Oncocytic; Study_ID: S011002",Other,,
1964,988635,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Necrosis, Oncocytic; Study_ID: S011002",Other,,
1965,988636,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Edema; Study_ID: S011002",Other,,
1966,994932,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S030120",Other,,
1967,994933,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Necrosis, Oncocytic; Study_ID: S030120",Other,,
1968,994934,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S030120",Other,,
1969,994935,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Degeneration; Study_ID: S030120",Other,,
1970,994936,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Necrosis, Oncocytic; Study_ID: S030120",Other,,
1971,994937,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Glycogen Accumulation; Study_ID: S030120",Other,,
1972,994938,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Extramedullary Hematopoiesis; Study_ID: S030120",Other,,
1973,994939,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S030120",Other,,
1974,994940,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Increased Mitoses; Study_ID: S030120",Other,,
1975,994941,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Necrosis, Apoptotic; Study_ID: S030120",Other,,
1976,994942,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S030120",Other,,
1977,994943,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Subcapsular, Degeneration; Study_ID: S030120",Other,,
1978,994944,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Hypertrophy; Study_ID: S030120",Other,,
1979,994945,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Lipid Accumulation, Macrovesicular; Study_ID: S030120",Other,,
1980,994946,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Subcapsular, Necrosis, Oncocytic; Study_ID: S030120",Other,,
1981,994947,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S030120",Other,,
1982,994948,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Degeneration; Study_ID: S030120",Other,,
1983,994949,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Subcapsular, Mineralization; Study_ID: S030120",Other,,
1984,994950,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Necrosis, Oncocytic; Study_ID: S030120",Other,,
1985,994951,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Neutrophilic; Study_ID: S030120",Other,,
1986,994952,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Mineralization; Study_ID: S030120",Other,,
1987,994953,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S030120",Other,,
1988,994954,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Midzonal, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S030120",Other,,
1989,994955,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Lipid Accumulation, Macrovesicular; Study_ID: S030120",Other,,
1990,994956,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Necrosis, Oncocytic; Study_ID: S030120",Other,,
1991,994957,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S011002",Other,,
1992,994958,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Diffuse, Hypertrophy; Study_ID: S011002",Other,,
1993,994959,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Erythrophagocytosis; Study_ID: S011002",Other,,
1994,994960,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Glycogen Accumulation; Study_ID: S011002",Other,,
1995,994961,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Subcapsular, Necrosis, Oncocytic; Study_ID: S011002",Other,,
1996,994962,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S011002",Other,,
1997,994963,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Bile Duct Dilatation; Study_ID: S011002,Other,,
1998,994964,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Capsule, Mesothelial Cell, Hyperplasia; Study_ID: S011002",Other,,
1999,994965,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular Fibrosis; Study_ID: S011002,Other,,
2000,994966,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Atrophy; Study_ID: S011002",Other,,
2001,994967,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Cytoplasm, Eosinophilia; Study_ID: S011002",Other,,
2002,994968,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 7 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Degeneration; Study_ID: S011002",Other,,
2003,1006805,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Necrosis, Oncocytic; Study_ID: S030120",Other,,
2004,1009249,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S030120",Other,,
2005,1009250,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Subcapsular, Necrosis, Oncocytic; Study_ID: S030120",Other,,
2006,1009251,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S030120",Other,,
2007,1009252,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Degeneration; Study_ID: S030120",Other,,
2008,1009253,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Necrosis, Oncocytic; Study_ID: S030120",Other,,
2009,1009254,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: S030120",Other,,
2010,1009255,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S030120",Other,,
2011,1009256,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Necrosis, Apoptotic; Study_ID: S030120",Other,,
2012,1009257,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Subcapsular, Degeneration; Study_ID: S030120",Other,,
2013,1009258,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Hypertrophy; Study_ID: S030120",Other,,
2014,1009259,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Lipid Accumulation, Macrovesicular; Study_ID: S030120",Other,,
2015,1009260,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Extramedullary Hematopoiesis; Study_ID: S030120",Other,,
2016,1009261,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S030120",Other,,
2017,1009262,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Subcapsular, Mineralization; Study_ID: S030120",Other,,
2018,1009263,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Necrosis, Oncocytic; Study_ID: S030120",Other,,
2019,1009264,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S030120",Other,,
2020,1009846,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Neutrophilic; Study_ID: S030120",Other,,
2021,1009847,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Degeneration; Study_ID: S030120",Other,,
2022,1009848,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Increased Mitoses; Study_ID: S030120",Other,,
2023,1009849,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Mineralization; Study_ID: S030120",Other,,
2024,1009850,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Glycogen Accumulation; Study_ID: S030120",Other,,
2025,1009851,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Midzonal, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: S030120",Other,,
2026,1009852,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Lipid Accumulation, Macrovesicular; Study_ID: S030120",Other,,
2027,1009853,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 3 day; Dose: High; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Midzonal, Necrosis, Oncocytic; Study_ID: S030120",Other,,
2028,1015452,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Necrosis, Oncocytic; Study_ID: CVD040520",Other,,
2029,1015453,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: CVD040520",Other,,
2030,1015454,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular, Inflammatory Cell Infiltrate, Neutrophilic; Study_ID: CVD040520",Other,,
2031,1015455,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Lipid Accumulation, Microvesicular; Study_ID: CVD040520",Other,,
2032,1015456,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: CVD040520",Other,,
2033,1015457,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Clear Cell Focus; Study_ID: CVD040520,Other,,
2034,1015458,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Lipid Accumulation, Macrovesicular; Study_ID: CVD040520",Other,,
2035,1020998,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Diffuse, Hypertrophy; Study_ID: CVD040520",Other,,
2036,1020999,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: CVD040520",Other,,
2037,1021000,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: CVD040520",Other,,
2038,1021001,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Degeneration; Study_ID: CVD040520",Other,,
2039,1022871,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Necrosis, Oncocytic; Study_ID: CVD040520",Other,,
2040,1022872,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Glycogen Accumulation; Study_ID: CVD040520",Other,,
2041,1022873,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: CVD040520",Other,,
2042,1022874,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: CVD040520",Other,,
2043,1022875,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Increased Mitoses; Study_ID: CVD040520",Other,,
2044,1022876,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Lipid Accumulation, Microvesicular; Study_ID: CVD040520",Other,,
2045,1022877,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Necrosis, Apoptotic; Study_ID: CVD040520",Other,,
2046,1022878,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Hypertrophy; Study_ID: CVD040520",Other,,
2047,1022879,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Bile Duct Hyperplasia; Study_ID: CVD040520,Other,,
2048,1022880,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Hypertrophy; Study_ID: CVD040520",Other,,
2049,1022881,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Glycogen Accumulation; Study_ID: CVD040520",Other,,
2050,1022882,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Lipid Accumulation, Macrovesicular; Study_ID: CVD040520",Other,,
2051,1022883,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Fibrosis; Study_ID: CVD040520",Other,,
2052,1022884,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Capsule, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: CVD040520",Other,,
2053,1022885,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Lipid Accumulation, Microvesicular; Study_ID: CVD040520",Other,,
2054,1022886,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Necrosis, Oncocytic; Study_ID: CVD040520",Other,,
2055,1022887,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: CVD040520",Other,,
2056,1022888,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Centrilobular, Inflammatory Cell Infiltrate, Neutrophilic; Study_ID: CVD040520",Other,,
2057,1022889,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Lipid Accumulation, Microvesicular; Study_ID: CVD040520",Other,,
2058,1022890,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Clear Cell Focus; Study_ID: CVD040520,Other,,
2059,1022891,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Single; Time: 1 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Lipid Accumulation, Macrovesicular; Study_ID: CVD040520",Other,,
2060,1022892,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Diffuse, Hypertrophy; Study_ID: CVD040520",Other,,
2061,1022893,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: CVD040520",Other,,
2062,1022894,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Inflammatory Cell Infiltrate, Lymphoid; Study_ID: CVD040520",Other,,
2063,1022895,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Degeneration; Study_ID: CVD040520",Other,,
2064,1022896,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Necrosis, Oncocytic; Study_ID: CVD040520",Other,,
2065,1022897,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Glycogen Accumulation; Study_ID: CVD040520",Other,,
2066,1022898,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Nonzonal, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: CVD040520",Other,,
2067,1023481,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Increased Mitoses; Study_ID: CVD040520",Other,,
2068,1023482,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Lipid Accumulation, Microvesicular; Study_ID: CVD040520",Other,,
2069,1023483,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Necrosis, Apoptotic; Study_ID: CVD040520",Other,,
2070,1023484,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Periportal, Hypertrophy; Study_ID: CVD040520",Other,,
2071,1023485,1,3,,103532939,7858,Unspecified,,,,,DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Bile Duct Hyperplasia; Study_ID: CVD040520,Other,,
2072,1023486,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Hypertrophy; Study_ID: CVD040520",Other,,
2073,1023487,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Glycogen Accumulation; Study_ID: CVD040520",Other,,
2074,1023488,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Nonzonal, Lipid Accumulation, Macrovesicular; Study_ID: CVD040520",Other,,
2075,1023489,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Periportal, Fibrosis; Study_ID: CVD040520",Other,,
2076,1023490,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Capsule, Inflammatory Cell Infiltrate, Mixed Cell; Study_ID: CVD040520",Other,,
2077,1023491,1,3,,103532939,7858,Unspecified,,,,,"DrugMatrix: Regimen: Daily Repeat; Time: 5 day; Dose: Low; Vehicle: 100 % saline; Route: intraperitoneal | Dataset: Pathology; Tissue: Liver; Assay: Hepatocyte, Centrilobular, Lipid Accumulation, Microvesicular; Study_ID: CVD040520",Other,,
2078,1049617,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 102/5,Other,,
2079,1049618,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 102/5,Other,,
2080,1049619,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 102/5,Other,,
2081,1049620,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 102/5,Other,,
2082,1049621,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 102/5,Other,,
2083,1049622,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 102/6,Other,,
2084,1049623,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 102/6,Other,,
2085,1049624,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 102/6,Other,,
2086,1049625,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 102/6,Other,,
2087,1049626,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 102/6,Other,,
2088,1049627,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 102/7,Other,,
2089,1049628,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 102/7,Other,,
2090,1049629,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 102/7,Other,,
2091,1049630,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 102/7,Other,,
2092,1049631,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 102/7,Other,,
2093,1049632,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 102/8,Other,,
2094,1049633,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 102/8,Other,,
2095,1049634,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 102/8,Other,,
2096,1049635,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 102/8,Other,,
2097,1049636,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 102/8,Other,,
2098,1049637,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 102/9,Other,,
2099,1049638,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 102/9,Other,,
2100,1049639,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 102/9,Other,,
2101,1049640,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 102/9,Other,,
2102,1049641,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 102/9,Other,,
2103,1049920,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 102/10,Other,,
2104,1049921,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 102/10,Other,,
2105,1049922,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 102/10,Other,,
2106,1049923,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 102/10,Other,,
2107,1049924,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 102/10,Other,,
2108,1049925,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 102/11,Other,,
2109,1049926,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 102/11,Other,,
2110,1049927,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 102/11,Other,,
2111,1049928,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 102/11,Other,,
2112,1049929,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 102/11,Other,,
2113,1049930,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 102/12,Other,,
2114,1049931,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 102/12,Other,,
2115,1049932,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 102/12,Other,,
2116,1049933,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 102/12,Other,,
2117,1049934,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 102/12,Other,,
2118,1049935,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 102/13,Other,,
2119,1049936,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 102/13,Other,,
2120,1049937,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 102/13,Other,,
2121,1049938,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 102/13,Other,,
2122,1050658,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 3 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 102/13,Other,,
2123,1050659,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 102/14,Other,,
2124,1050660,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 102/14,Other,,
2125,1050661,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 102/14,Other,,
2126,1050662,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 102/14,Other,,
2127,1050663,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 6 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 102/14,Other,,
2128,1050664,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 102/15,Other,,
2129,1050665,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 102/15,Other,,
2130,1050666,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 102/15,Other,,
2131,1050667,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 102/15,Other,,
2132,1050668,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 9 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 102/15,Other,,
2133,1050669,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 102/16,Other,,
2134,1050670,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 102/16,Other,,
2135,1050671,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 102/16,Other,,
2136,1050672,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 102/16,Other,,
2137,1050673,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Single; Time: 24 hr; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 102/16,Other,,
2138,1050674,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 103/5,Other,,
2139,1050675,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 103/5,Other,,
2140,1050676,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 103/5,Other,,
2141,1050895,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 103/5,Other,,
2142,1050896,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 103/5,Other,,
2143,1050897,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 103/6,Other,,
2144,1050898,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 103/6,Other,,
2145,1050899,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 103/6,Other,,
2146,1050900,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 103/6,Other,,
2147,1050901,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 103/6,Other,,
2148,1050902,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 103/7,Other,,
2149,1050903,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 103/7,Other,,
2150,1050904,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 103/7,Other,,
2151,1050905,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 103/7,Other,,
2152,1050906,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 103/7,Other,,
2153,1050907,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 103/8,Other,,
2154,1050908,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 103/8,Other,,
2155,1050909,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 103/8,Other,,
2156,1050910,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 103/8,Other,,
2157,1050911,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Low; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 103/8,Other,,
2158,1050912,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 103/9,Other,,
2159,1050913,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 103/9,Other,,
2160,1050914,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 103/9,Other,,
2161,1050915,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 103/9,Other,,
2162,1050916,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 103/9,Other,,
2163,1050917,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 103/10,Other,,
2164,1050918,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 103/10,Other,,
2165,1050919,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 103/10,Other,,
2166,1050920,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 103/10,Other,,
2167,1050921,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 103/10,Other,,
2168,1050922,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 103/11,Other,,
2169,1050937,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 103/11,Other,,
2170,1050938,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 103/11,Other,,
2171,1050939,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 103/11,Other,,
2172,1050940,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 103/11,Other,,
2173,1050941,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 103/12,Other,,
2174,1050942,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 103/12,Other,,
2175,1050943,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 103/12,Other,,
2176,1050944,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 103/12,Other,,
2177,1050945,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: Middle; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 103/12,Other,,
2178,1050946,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 103/13,Other,,
2179,1050947,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 103/13,Other,,
2180,1050948,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 103/13,Other,,
2181,1050949,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 103/13,Other,,
2182,1050950,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 4 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 103/13,Other,,
2183,1050951,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 103/14,Other,,
2184,1050952,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 103/14,Other,,
2185,1050953,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 103/14,Other,,
2186,1050954,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 103/14,Other,,
2187,1050955,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 8 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 103/14,Other,,
2188,1050956,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 103/15,Other,,
2189,1050957,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 103/15,Other,,
2190,1050958,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 103/15,Other,,
2191,1050959,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 103/15,Other,,
2192,1050960,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 15 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 103/15,Other,,
2193,1050961,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: TERMBW (Terminal Body Weight); Study_ID: 103/16,Other,,
2194,1050962,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Liver Weight); Study_ID: 103/16,Other,,
2195,1050963,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Total Kidney Weight); Study_ID: 103/16,Other,,
2196,1050964,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Right Kidney Weight); Study_ID: 103/16,Other,,
2197,1050965,1,2,,103532939,7858,Unspecified,,,,,Open TG-GATES: Regimen: Daily Repeat; Time: 29 day; Dose: High; Route: Gavage | Dataset: Organ Weight; Assay: WEIGHT (Left Kidney Weight); Study_ID: 103/16,Other,,
2198,1159509,1,1,,144207398,7858,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
2199,1159509,1,1,,144213815,7858,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
2200,1159515,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
2201,1159515,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
2202,1159516,1,1,,144207398,7858,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
2203,1159516,1,1,,144213815,7858,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
2204,1159517,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
2205,1159517,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
2206,1159518,1,1,,144207398,7858,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
2207,1159518,1,1,,144213815,7858,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
2208,1159519,1,1,,144207398,7858,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
2209,1159519,1,1,,144213815,7858,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
2210,1159520,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
2211,1159520,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
2212,1159521,1,1,,144207398,7858,Inactive,15928672.0,19885.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
2213,1159521,1,1,,144213815,7858,Inactive,15928672.0,19885.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
2214,1159523,1,1,,144207398,7858,Inconclusive,15928672.0,19885.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
2215,1159523,1,1,,144213815,7858,Inactive,15928672.0,19885.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
2216,1159525,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
2217,1159525,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
2218,1159526,1,1,,144207398,7858,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
2219,1159526,1,1,,144213815,7858,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
2220,1159527,1,1,,144207398,7858,Inactive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
2221,1159527,1,1,,144213815,7858,Inactive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
2222,1159528,1,1,,144207398,7858,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
2223,1159528,1,1,,144213815,7858,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
2224,1159529,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
2225,1159529,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
2226,1159531,1,1,,144207398,7858,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
2227,1159531,1,1,,144213815,7858,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
2228,1159551,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
2229,1159551,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
2230,1159552,1,1,,144207398,7858,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
2231,1159552,1,1,,144213815,7858,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
2232,1159553,2,1,,144207398,7858,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
2233,1159553,2,1,,144213815,7858,Inactive,325495463.0,5914.0,76.9588,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
2234,1159555,1,1,,144207398,7858,Inactive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
2235,1159555,1,1,,144213815,7858,Inactive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
2236,1224834,3,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
2237,1224834,3,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
2238,1224835,1,1,,144207398,7858,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
2239,1224835,1,1,,144213815,7858,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
2240,1224836,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
2241,1224836,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
2242,1224837,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
2243,1224837,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
2244,1224838,1,1,,144207398,7858,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
2245,1224838,1,1,,144213815,7858,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
2246,1224839,1,1,,144207398,7858,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
2247,1224839,1,1,,144213815,7858,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
2248,1224840,3,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
2249,1224840,3,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
2250,1224841,3,1,,144207398,7858,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
2251,1224841,3,1,,144213815,7858,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
2252,1224842,3,1,,144207398,7858,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
2253,1224842,3,1,,144213815,7858,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
2254,1224843,1,1,,144207398,7858,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
2255,1224843,1,1,,144213815,7858,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
2256,1224844,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
2257,1224844,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
2258,1224845,1,1,,144207398,7858,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
2259,1224845,1,1,,144213815,7858,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
2260,1224846,1,1,,144207398,7858,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
2261,1224846,1,1,,144213815,7858,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
2262,1224847,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
2263,1224847,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
2264,1224848,3,1,,144207398,7858,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
2265,1224848,3,1,,144213815,7858,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
2266,1224849,3,1,,144207398,7858,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
2267,1224849,3,1,,144213815,7858,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
2268,1224867,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
2269,1224867,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
2270,1224868,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
2271,1224868,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
2272,1224869,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
2273,1224869,1,1,,144213815,7858,Active,,,43.6412,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
2274,1224870,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
2275,1224870,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
2276,1224871,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
2277,1224871,1,1,,144213815,7858,Active,,,34.6654,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
2278,1224872,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
2279,1224872,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
2280,1224873,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
2281,1224873,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
2282,1224874,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
2283,1224874,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
2284,1224875,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
2285,1224875,1,1,,144213815,7858,Active,,,27.5357,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
2286,1224876,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
2287,1224876,1,1,,144213815,7858,Active,,,24.5412,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
2288,1224877,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
2289,1224877,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
2290,1224878,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
2291,1224878,1,1,,144213815,7858,Active,,,24.5412,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
2292,1224879,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
2293,1224879,1,1,,144213815,7858,Active,,,24.5412,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
2294,1224880,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
2295,1224880,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
2296,1224881,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
2297,1224881,1,1,,144213815,7858,Active,,,38.8952,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
2298,1224882,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
2299,1224882,1,1,,144213815,7858,Active,,,38.8952,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
2300,1224883,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
2301,1224883,1,1,,144213815,7858,Active,,,24.5412,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
2302,1224884,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
2303,1224884,1,1,,144213815,7858,Active,,,27.5357,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
2304,1224885,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
2305,1224885,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
2306,1224886,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
2307,1224886,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
2308,1224887,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
2309,1224887,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
2310,1224888,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
2311,1224888,1,1,,144213815,7858,Active,,,27.5357,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
2312,1224889,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
2313,1224889,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
2314,1224890,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
2315,1224890,1,1,,144213815,7858,Active,,,27.5357,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
2316,1224892,1,1,,144207398,7858,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
2317,1224892,1,1,,144213815,7858,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
2318,1224893,1,1,,144207398,7858,Inactive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
2319,1224893,1,1,,144213815,7858,Inactive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
2320,1224894,1,1,,144207398,7858,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
2321,1224894,1,1,,144213815,7858,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
2322,1224895,1,1,,144207398,7858,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
2323,1224895,1,1,,144213815,7858,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
2324,1224896,1,1,,144207398,7858,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
2325,1224896,1,1,,144213815,7858,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
2326,1259241,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
2327,1259241,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
2328,1259242,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
2329,1259242,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
2330,1259243,1,1,,144207398,7858,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
2331,1259243,1,1,,144213815,7858,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
2332,1259244,1,1,,144207398,7858,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
2333,1259244,1,1,,144213815,7858,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
2334,1259247,1,1,,144207398,7858,Inactive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
2335,1259247,1,1,,144213815,7858,Inconclusive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
2336,1259248,1,1,,144207398,7858,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
2337,1259248,1,1,,144213815,7858,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
2338,1259364,1,1,,144207398,7858,Active,1013403374.0,9734.0,28.5044,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
2339,1259364,1,1,,144213815,7858,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
2340,1259365,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
2341,1259365,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
2342,1259366,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
2343,1259366,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
2344,1259367,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
2345,1259367,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
2346,1259368,1,1,,144207398,7858,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
2347,1259368,1,1,,144213815,7858,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
2348,1259369,1,1,,144207398,7858,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
2349,1259369,1,1,,144213815,7858,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
2350,1259377,1,1,,144207398,7858,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
2351,1259377,1,1,,144213815,7858,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
2352,1259378,1,1,,144207398,7858,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
2353,1259378,1,1,,144213815,7858,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
2354,1259379,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
2355,1259379,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
2356,1259380,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
2357,1259380,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
2358,1259381,1,1,,144207398,7858,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
2359,1259381,1,1,,144213815,7858,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
2360,1259382,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
2361,1259382,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
2362,1259383,1,1,,144207398,7858,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
2363,1259383,1,1,,144213815,7858,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
2364,1259384,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
2365,1259384,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
2366,1259385,1,1,,144207398,7858,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
2367,1259385,1,1,,144213815,7858,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
2368,1259386,1,1,,144207398,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
2369,1259386,1,1,,144213815,7858,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
2370,1259387,1,1,,144207398,7858,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
2371,1259387,1,1,,144213815,7858,Inconclusive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
2372,1259388,1,1,,144207398,7858,Inconclusive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
2373,1259388,1,1,,144213815,7858,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
2374,1259390,1,1,,144207398,7858,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
2375,1259390,1,1,,144213815,7858,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
2376,1259391,1,1,,144207398,7858,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
2377,1259391,1,1,,144213815,7858,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
2378,1259392,1,1,,144207398,7858,Inactive,109731339.0,2737.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
2379,1259392,1,1,,144213815,7858,Inactive,109731339.0,2737.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
2380,1259393,1,1,,144207398,7858,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
2381,1259393,1,1,,144213815,7858,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
2382,1259394,1,1,,144207398,7858,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
2383,1259394,1,1,,144213815,7858,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
2384,1259395,1,1,,144207398,7858,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
2385,1259395,1,1,,144213815,7858,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
2386,1259396,1,1,,144207398,7858,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
2387,1259396,1,1,,144213815,7858,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
2388,1259401,1,1,,144207398,7858,Inconclusive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
2389,1259401,1,1,,144213815,7858,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
2390,1259402,1,1,,144207398,7858,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
2391,1259402,1,1,,144213815,7858,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
2392,1259403,1,1,,144207398,7858,Inconclusive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
2393,1259403,1,1,,144213815,7858,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
2394,1259404,1,1,,144207398,7858,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
2395,1259404,1,1,,144213815,7858,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
2396,1259407,1,1,,363898697,7858,Active,,,,,CCRIS mutagenicity studies,Other,,
2397,1259411,1,1,,363898697,7858,Inactive,,,,,CCRIS carcinogenicity studies,Other,,
